Skip to main content
eLife logoLink to eLife
. 2018 Jun 7;7:e36381. doi: 10.7554/eLife.36381

Structures of two aptamers with differing ligand specificity reveal ruggedness in the functional landscape of RNA

Andrew John Knappenberger 1,2,, Caroline Wetherington Reiss 1,2,, Scott A Strobel 1,2,
Editor: Timothy W Nilsen3
PMCID: PMC6031431  PMID: 29877798

Abstract

Two classes of riboswitches related to the ykkC guanidine-I riboswitch bind phosphoribosyl pyrophosphate (PRPP) and guanosine tetraphosphate (ppGpp). Here we report the co-crystal structure of the PRPP aptamer and its ligand. We also report the structure of the G96A point mutant that prefers ppGpp over PRPP with a dramatic 40,000-fold switch in specificity. The ends of the aptamer form a helix that is not present in the guanidine aptamer and is involved in the expression platform. In the mutant, the base of ppGpp replaces G96 in three-dimensional space. This disrupts the S-turn, which is a primary structural feature of the ykkC RNA motif. These dramatic differences in ligand specificity are achieved with minimal mutations. ykkC aptamers are therefore a prime example of an RNA fold with a rugged fitness landscape. The ease with which the ykkC aptamer acquires new specificity represents a striking case of evolvability in RNA.

Research organism: None

eLife digest

DNA’s iconic double helix has made it possibly the most widely recognized biological molecule. The closely related RNA, however, is less well known but just as vital. In contrast with DNA’s typical rigid structure, RNA is more flexible and can fold into a wide range of shapes; this allows RNA molecules to have many jobs.

Some RNA molecules form structures called riboswitches. As the name suggests, these act as molecular switches that help cells to respond to the presence of important small molecules. When a riboswitch encounters the right molecule, it changes shape, which in turn changes how the cell behaves. It is very difficult, if not impossible, to predict how a riboswitch recognizes its preferred small molecule. To address this, scientists use a technique called X-ray crystallography to directly examine the riboswitch’s structure.

Knappenberger, Reiss and Strobel have now determined the structures of two recently discovered riboswitches. The two switches detect molecules called PRPP and ppGpp, respectively. These riboswitches are structurally similar to one that binds to a very different type of chemical called guanidine. The aim was to understand how similar switches respond to different signals. The results reveal that a PRPP riboswitch could become a ppGpp riboswitch just by making a single change to the RNA sequence.

Many scientists believe RNA preceded DNA and proteins in some of the earliest organisms on Earth. Understanding how RNAs have evolved and diversified could thus help to understand how early life developed. The results may also help to design synthetic riboswitches for a variety of uses. Since many riboswitches are unique to bacteria, this work could also contribute to the search for new antibiotics.

Introduction

RNA has diverse functional capabilities, which has driven speculation that the first organisms may have been RNA-based (Breaker, 2012; Crick, 1968; Gilbert, 1986; Orgel, 2004; 1968; Strobel, 2001; Woese et al., 1966). For this hypothesis to be plausible, RNA must be adaptable; that is, capable of acquiring new functions through mutation. In the field of evolutionary biology, this trait is described as evolvability (Kirschner and Gerhart, 1998; Wagner and Altenberg, 1996). Evolvability is the propensity of a system to produce a mutated genotype that yields a beneficial phenotype under new selective pressures (Ancel and Fontana, 2000; Kirschner and Gerhart, 1998; Wagner, 2008; Wagner and Altenberg, 1996). Often, this occurs through mutation of an existing gene through divergent evolution. For example, bacterial β-lactamases demonstrate significant evolvability through mutations in the Ω-loop. This loop determines substrate specificity, but mutation or outright deletion of the loop does not dramatically affect the overall structure of the protein (Banerjee et al., 1998; Hujer et al., 2001; Kurokawa et al., 2000; Wachino et al., 2004). This locus of evolvability allows the protein to adapt to the selective pressures of novel antibiotics. The concept of evolvability has also been studied in RNA, including a notable paper by Draghi et al. (Draghi et al., 2010). This study found that adaptation rate is hastened when the build-up of some phenotypically neutral mutations occurs and the web of accessible phenotypes becomes broad. The speed at which an organism adapts is determined by this, as well as the ruggedness of the fitness landscape, which is related to the number of mutations required to reach a new fitness maximum.

Variant riboswitches yield insight into the evolvability of RNA. Riboswitch variants are naturally occurring riboswitches with a conserved overall fold but altered ligand specificity. Examples include the guanine/adenine riboswitches and the cyclic-di-GMP/cyclic-GMP-AMP riboswitches (Kellenberger et al., 2015; Mandal et al., 2003; Mandal and Breaker, 2004; Ren et al., 2015; Serganov et al., 2004; Smith et al., 2009; Sudarsan et al., 2008). Bioinformatic and structural studies of the guanine/adenine and cyclic-di-GMP/cyclic-GMP-AMP aptamers showed that the altered specificity occurs simply by changing base pairing between the RNA and ligand. Recently, the ykkC RNA motif was identified as binding to multiple, chemically dissimilar ligands, which makes this specific scaffold a compelling target for structural studies of RNA evolvability (Sherlock et al., 2018a; 2018b; Nelson et al., 2017).

The ykkC RNA was discovered in 2004 and its ligand(s) remained unknown for over a decade (Barrick et al., 2004; Nelson et al., 2017). In 2017, Nelson et al. published two pivotal discoveries regarding this motif: (1) the majority of these RNAs bind specifically to the guanidinium cation and (2) the ykkC riboswitch class can be divided into at least two subtypes. Subtype 1, which has approximately 1500 known examples, is the major class now known as the guanidine-I riboswitch. Subtype 2 was defined as all variants of this motif that do not recognize guanidine. The subtype 2 variants are overall quite similar to guanidine-I riboswitches. They retain the same overall fold, but possess a few characteristic differences at nucleotides crucial for guanidine binding. Notably, most of these differences are centered around a classic S-turn motif that forms the binding pocket of the guanidine-I riboswitch. A similar overall architecture with key differences in binding pocket nucleotides is a signature characteristic of a riboswitch variant (Weinberg et al., 2017).

Variant ykkC RNAs are found upstream of a variety of genes, although two major groups are apparent. One major group regulates amino acid synthesis and transport genes, which are upregulated during the stringent response. The other regulates de novo purine biosynthesis, which produces purine nucleotides from smaller metabolites under conditions where intact nucleobases are not available (Sherlock et al., 2018a; 2018bEbbole and Zalkin, 1987; 1989). These riboswitches were designated as ykkC subtype 2a and 2b, respectively. When compared to guanidine riboswitches, subtypes 2a and 2b harbor systematic changes to residues directly involved in guanidine binding, which led to the suggestion that they may have different ligand specificity. For example, where guanidine riboswitches have a conserved adenosine residue (A46 in the guanidine-I structure solved by Reiss et al.), subtypes 2a and 2b have a pyrimidine (C49 in the present study) (Battaglia et al., 2017; Reiss et al., 2017). Sorting the entire ykkC class by the identity of this position alone results in a strikingly complete segregation of guanidine-related gene contexts from those that are incongruent with mitigation of guanidine toxicity (Nelson et al., 2017). Alignment of subtype 1, 2a, and 2b sequences also shows an extension of conservation at both the 5′ and 3′ ends of the 2a and 2b aptamer subtypes. These key differences in conserved residues and gene contexts suggested that these ykkC variants have altered ligand specificity while retaining the same overall architecture.

Subtype 2a and 2b ykkC riboswitches do not retain the ligand specificity of their parent riboswitch. Using transcription termination and in-line probing assays, Sherlock et al. found that neither subtype is responsive to guanidine (Sherlock et al., 2018a; 2018b). Instead, subtype 2a is responsive to guanosine tetra/pentaphosphate ((p)ppGpp, hereafter referred to as ppGpp), an alarmone that regulates the stringent response (Cashel and Gallant, 1969; Dalebroux and Swanson, 2012; Gaca et al., 2015). Subtype 2b is responsive to phosphoribosyl pyrophosphate (PRPP), a precursor in purine biosynthesis. Like the guanidine riboswitch, both function as ON switches. The consensus motifs for subtypes 2a and 2b are remarkably similar to each other, even relative to other ykkC RNAs (Sherlock et al., 2018a; 2018b). The most apparent difference is a highly-conserved guanosine (G96 in this study) in subtype 2b that is not conserved in subtype 2a. This residue is equivalent to G89 in the guanidine-I riboswitch and is a conserved part of its S-turn motif. Although bioinformatic data suggest that variation in G96 is central to the structural differences between subtype 2a and 2b riboswitches, its precise role in this context remains uncertain.

Unlike guanidine, the biological roles of PRPP and ppGpp are both well-documented. PRPP is an activated form of ribose 5-phosphate, and a major macromolecular building block (Hove-Jensen et al., 2017). It is a central metabolite used in biosynthesis of purine and pyrimidine nucleotides, the amino acids histidine and tryptophan, nicotinamide adenine dinucleotide, thiamine diphosphate, flavins, and pterins (Hove-Jensen, 1988; Jiménez et al., 2008; White, 1996). The centrality of PRPP within metabolism makes it an appealing target for regulation. ppGpp is an alarmone that initiates the stringent response, a global reaction to nutrient starvation in bacteria (Cashel and Gallant, 1969; Cashel and Kalbacher, 1970; O'Farrell, 1978; Potrykus and Cashel, 2008). Amino acid starvation triggers synthesis of ppGpp and it binds to a variety of effector molecules to initiate sweeping changes in the cell’s transcriptional profile, including a reduction in tRNA and rRNA synthesis and an increase in transcription of amino acid biosynthesis genes (Cashel, 1970; Paul et al., 2005; Ryals et al., 1982; van Ooyen et al., 1976). Consistent with a role in the stringent response, the ppGpp riboswitch turns on transcription of amino acid biosynthesis and transport genes in response to alarmone binding.

Although the tree topology is unknown, a common ancestral RNA likely diverged to recognize guanidine, PRPP, and ppGpp in spite of the chemical and structural diversity among these ligands. PRPP and ppGpp are more similar to each other than either is to guanidine, which reflects the greater similarity in their aptamers. While guanidine harbors a single delocalized positive charge, PRPP and ppGpp harbor multiple separate loci of negative charge. Guanidine is small and achiral with three-fold rotational symmetry, while PRPP and ppGpp are larger, chiral, asymmetric molecules. PRPP and ppGpp both contain ribose sugars and pyrophosphate moieties, but ppGpp has an entire guanine base that PRPP lacks. Bioinformatic evidence suggests that the 2a and 2b aptamers represent an especially concise solution to a central biophysical problem: biologically relevant switching entails recognition of a cognate ligand and rejection of structurally similar alternatives.

We set out to determine how three RNA elements with a common scaffold could recognize such dissimilar ligands with high specificity. Central questions include how a polyanionic macromolecule differentially recognizes two distinct small polyanions, and how the presence or absence of the guanine base changes the RNA’s recognition strategy. To address these questions of molecular recognition by RNA, we report the near-atomic resolution structure of a native ykkC 2b riboswitch in complex with PRPP via X-ray crystallography. We also convert this construct into a ppGpp aptamer with a single G96A mutation and present the structure of the mutant bound to ppGpp. This structural and biochemical information reveals how the ykkC RNA differentiates between ppGpp and PRPP. This study showcases the functional plasticity of RNAs and the evolvability of RNA function from a single structural scaffold.

Results

The structure of the wild-type PRPP aptamer and a single point mutant ppGpp aptamer

To understand the basis of ligand recognition by the PRPP riboswitch, we determined the crystal structure of the aptamer domain of the ykkC 2b riboswitch from Thermoanaerobacter mathranii at 2.5 Å resolution in the presence of its native ligand, PRPP (Supplementary file 1). PRPP is an activated metabolic intermediate. As a result, it is highly unstable. It degrades on a time course of minutes to hours via several mechanisms in the presence of divalent metal ions, acidic or basic pH, and/or elevated temperatures (Dennis et al., 2000; Hove-Jensen et al., 2017; Khorana et al., 1958; 1955; Meola et al., 2003; Remy et al., 1955). However, binding to the PRPP riboswitch aptamer domain protects PRPP on a time scale of hours to days (Figure 1—figure supplement 1). The stabilizing effect of the aptamer permitted crystals of the intact complex to be observed after two days. Once formed, unfrozen crystals disappeared after approximately five to ten days, underscoring the need for prompt crystallization and cryogenic preservation in this study. The structure was solved by molecular replacement using the guanidine-I aptamer as an initial model. After model building and refinement, the model fit the data with an Rwork of 0.216 and an Rfree of 0.253.

Like its parent aptamer, the PRPP riboswitch contains two adjacent helical stacks (Figure 1). P3 forms a large portion of the binding pocket, and a conserved loop at the end of P3 docks into P1a. This allows conserved nucleotides from P1a to participate in ligand recognition. P1, P1a, P1b, and P2 together form a continuous coaxial stack adjacent to P3. However, unlike the guanidine aptamer, the PRPP aptamer has structured tails at the 5′ and 3′ ends that are not conserved in the guanidine riboswitch. The ends pair to form an additional short helix that we have termed P0, resulting in a four-way junction between P0, P1, P2, and P3. P0 coaxially stacks with P3 and extends the binding pocket for recognition of the larger PRPP ligand. The overall architecture of the PRPP aptamer reveals that it is a rather conservative adaptation of the guanidine aptamer with key differences that allow for PRPP recognition.

Figure 1. Overall structure of the PRPP riboswitch and its G96A mutant, which is a ppGpp aptamer.

(A) Consensus sequence of the PRPP riboswitch, adapted from Sherlock et al. (Sherlock et al., 2018b). The secondary structure has been updated to show structural information gained from the present study. The sequence is depicted as in Sherlock et al. (see key). Nucleotides noted in blue are important bioinformatic differences between PRPP riboswitches and guanidine riboswitches. Base pair notation is as published previously (Leontis and Westhof, 2001). (B) Secondary structure of the PRPP riboswitch aptamer from T. mathranii. Nucleotides are colored by paired region. Paired regions are indicated in bold. Sequence numbering is indicated in gray. Nucleotides that directly contact PRPP are circled in red, and arrows indicate strand connectivity. (C) Crystal structure of the PRPP riboswitch. Chain A is shown. The RNA is depicted as a cartoon and PRPP is depicted as yellow spheres. Nucleotides are colored by paired region as in B. (D) Crystal structure of the G96A mutant. Chain A is shown. The RNA is depicted as a cartoon and ppGpp is depicted as green spheres. Nucleotides are colored by paired region as in B.

Figure 1—source data 1. Summary of fitted binding data without Bmax constraints.
DOI: 10.7554/eLife.36381.006
Figure 1—source data 2. Raw binding data.
DOI: 10.7554/eLife.36381.007

Figure 1.

Figure 1—figure supplement 1. Autoradiograph of a representative PAGE gel from dissociation constant determination for the PRPP aptamer.

Figure 1—figure supplement 1.

The higher of the two bands represents intact PRPP, while the lower band represents degradation products. The leftmost lane is purified PRPP. This leftmost lane represents a sample of PRPP that was purified and eluted but not subjected to the reaction conditions. Each pair of lanes thereafter represents one dialysis cassette. The concentration of aptamer added to the cassette in micromolar is depicted above each pair. The concentration of aptamer in crystallization experiments was 150 μM, three-fold greater than the highest concentration used in determining the dissociation constant for wild type RNA. ‘L’ is the side of the cassette to which PRPP ligand was initially added. ‘R’ is the side of the cassette to which RNA aptamer was initially added. After overnight incubation at room temperature, material recovered from dialysis cassettes was electrophoresed to separate intact PRPP from degradation products. PRPP incubated in the presence of aptamer experienced significant protection relative to unbound PRPP, permitting the use of this unstable metabolite in the present structural and biophysical studies.
Figure 1—figure supplement 2. Data from equilibrium dialysis experiments and fits used to calculate dissociation constants.

Figure 1—figure supplement 2.

All experiments were performed in triplicate and the standard deviation for each data point is shown using black error bars. (A) wild type RNA binding to PRPP (purple) and ppGpp (green). The ppGpp complex did not quite reach saturation, so the Bmax was constrained to equal the Bmax value from the fit for ppGpp binding to the G96A mutant. (B) G96A mutant binding to PRPP (purple) and ppGpp (green). PRPP reached just 20% bound at 400 μM RNA, so the Bmax was constrained to equal the Bmax value from the fit for PRPP binding to wild type RNA.

Although PRPP is unstable in solution, it has high occupancy in this crystal structure. PRPP is modeled with an occupancy of 1, and its B factors refined similarly to those of nearby residues. The quality of the fit between the electron density data and this model shows that a combination of protection by the riboswitch and a vast molar excess of ligand permitted a high degree of aptamer saturation when data were collected.

PRPP is a potentially challenging ligand for RNA to recognize; it has three negatively charged phosphate groups and lacks a moiety resembling a nucleobase. PRPP is known to interact with two divalent metal ions per molecule in solution. The 5-phosphate associates weakly with one metal and the pyrophosphate moiety more strongly coordinates a second metal (Thompson et al., 1978). In the current model, these two metals are present in the complex with the riboswitch (Figure 2). One metal (M1) associates with the 5-phosphate, and the second metal (M2) associates with the pyrophosphate. Both metals form contacts bridging PRPP and the RNA aptamer. A third metal ion, M3, forms a water-mediated coordination to the 5-phosphate. The same water molecule also coordinates M1. The three phosphate groups are major elements of recognition via interactions with nucleobase amines and divalent metal ions.

Figure 2. The binding pocket of the PRPP riboswitch.

Figure 2.

(A) Crystal structure of the ligand-binding site in chain A. Relative to Figure 1, the structure is rotated 180° about the y axis. PRPP is depicted as sticks and colored by element with purple carbons. Nucleotides are depicted as blue sticks. Metal ions are depicted as gray spheres. Individual nucleotides and metals are labeled. An FO–FC map contoured at 2.5 σ is shown as a gray mesh. The map was calculated using an otherwise complete model lacking PRPP, M1, and M2. (B) Ligand interaction map. The map is colored essentially as in A. All RNA and metal contacts to PRPP are shown. Dashed black lines indicate hydrogen bonds. Solid black lines indicate coordination to a metal ion. Brackets indicate interactions shown in individual panels of Figure 3.

This construct crystallizes in the presence of BaCl2, so both Ba2+ and Mg2+ are present in the crystallization condition. M1 and M3 are modeled as Ba2+ due to the appearance of large positive peaks in the electron density map when they are modeled as Mg2+. M2 is modeled as Mg2+, but exhibits coordination distances higher than expected for this species (Figure 3—figure supplement 1). The aptamer binds PRPP with nearly equal affinity in the presence of either Ba2+ or Mg2+ alone (2.0 ± 0.4 and 2.0 ± 0.3 µM, respectively). Given that both metals support binding, we expect that there may be partial occupancy of these two species that cannot be resolved at this resolution.

The 5-phosphate of PRPP experiences recognition by a metal ion and the amino groups of conserved nucleotides (Figure 3A). The N1 and N2 of G48 form hydrogen bonds with two phosphate oxygens, while the N4 of C78 hydrogen bonds to the third non-bridging phosphate oxygen. The 5-phosphate also coordinates M1, which is held in place by coordination interactions with a non-bridging phosphate oxygen of C77 and the O2 of C49. The residue equivalent to C49 is conserved as an adenosine in the guanidine-I riboswitch but is a pyrimidine in PRPP and ppGpp riboswitches, and the identity of residue 49 was used as a marker to distinguish between these two variants (Sherlock et al., 2018a; 2018b). The O6 of G48 coordinates M3, but M3 is too distant from the 5-phosphate to be directly coordinated by it.

Figure 3. Notable contacts to the PRPP ligand in chain A. PRPP is depicted as sticks and colored by element with purple carbons.

Nucleotides are depicted as sticks and colored by element with blue carbons. Individual nucleotides and metals are labeled. Dashed black lines indicate hydrogen bonds. A dashed green line shows the lone pair-π interaction between A103 and G105. Solid black lines indicate coordination to a metal ion. Relative to Figure 1, the structure is rotated 180° about the y axis. Panel A is additionally rotated nearly 90° about the x axis. Panel D is rotated approximately 45° about the x axis in the opposite direction. (A) Contacts among the 5-phosphate of PRPP, residues G48, C49, C77, and metal ions M1 and M3. (B) Hydrogen bonds between the ribose of PRPP and residues C77, G96, and G104. (C) Coordination of metal M2 by PRPP and residue G6. (D) Recognition of the pyrophosphate group of PRPP by residues A5, G6, A101, and G105.

Figure 3.

Figure 3—figure supplement 1. Coordination of metals by chain A of the PRPP aptamer.

Figure 3—figure supplement 1.

PRPP is depicted as sticks and colored by element with purple carbons. Nucleotides are depicted as sticks and colored by element with blue carbons. Individual nucleotides and metals are labeled. Solid black lines indicate coordination to a metal ion, and coordination distances in Å are indicated. (A) Coordination of M1. (B) Coordination of M2. (C) Coordination of M3.

The ribose moiety of PRPP also makes extensive interactions with the RNA aptamer (Figure 3B). The sugar edge of G96 forms hydrogen bonds with the 2- and 3-hydroxyl groups. The N4 of C77 donates a hydrogen bond to the ribose oxygen, and the N1 group of G104 donates a hydrogen bond to the 2-hydroxyl group. These three residues are all highly conserved in the consensus sequence of this aptamer. At 2.5 Å resolution, conclusive determination of the sugar pucker is not possible, but a C2-endo pucker is the most likely conformation in this complex and it fits the electron density data well. This conformation avoids a steric clash between the 2-hydroxyl and the β-phosphate and allows the 3-hydroxyl to coordinate M2. This conformation is also consistent with previously reported structures of PRPP in complex with macromolecules (Evans et al., 2014; González-Segura et al., 2007; Héroux et al., 2000).

The P0 region of the aptamer extends below P3 and permits a suite of interactions with the pyrophosphate group of PRPP (Figure 3C–D). The β-phosphate of PRPP is more extensively recognized than the α-phosphate. The O6 of G6 coordinates M2, which in turn forms several interactions with the pyrophosphate group (Figure 3C). The N6 group of the weakly conserved A101 (>75% conserved as a purine) contacts a non-bridging oxygen of the α-phosphate (Figure 3D). The N6 group of A5 and the N1 groups of G6 and G105 make direct contacts with non-bridging oxygens of the β-phosphate. An abrupt deformation in the local backbone conformation positions A103 under G105, allowing a lone pair-π interaction to form between the O6 atom of G105 and the six-membered ring of A103 (Chawla et al., 2017; Egli and Sarkhel, 2007; Ran and Hobza, 2009; Sarkhel and Desiraju, 2003; Singh and Das, 2015). The present results show that the PRPP aptamer recognizes its ligand through a shifted and extended helical ligand-binding region, allowing for the retention of bound metal ions and extensive hydrogen bond donation to phosphate groups.

The intracellular PRPP concentration in bacteria is estimated to be in the millimolar range (Hove-Jensen et al., 2017; Jendresen et al., 2011; Jensen et al., 1979; Nygaard and Smith, 1993; Saxild and Nygaard, 1991; Schneider and Gourse, 2004; Yaginuma et al., 2015). However, enzymes and protein regulatory elements that sense PRPP concentrations in bacteria typically have micromolar dissociation (Kd) or Michaelis (KM) constants (Bera et al., 2003; Hove-Jensen et al., 2017; Jørgensen et al., 2008). Sherlock and colleagues recently found that the T50 (the ligand concentration that produces half-maximal effect) of a PRPP riboswitch in transcription termination assays is 90 μM (Sherlock et al., 2018b). We determined the Kd of the riboswitch aptamer domain for PRPP (Table 1, see also Figure 1—figure supplement 2A) by equilibrium dialysis using radiolabeled [β-33P]-PRPP. This assay yields a Kd of 2.0 ± 0.3 μM. There are two notable differences between the present experimental system and that employed by Sherlock et al. First and most importantly, the present study examines binding affinity in an isolated aptamer domain, while Sherlock et al. focused on the ability of the full riboswitch to terminate transcription. The full system is governed by the kinetics of ligand association and RNA folding, while the present experimental system only measures the thermodynamics of ligand binding. Also, in this study, [β-33P]-PRPP was used in trace quantities and the amount of intact PRPP remaining in each sample was carefully measured to deconvolute the counts obtained from intact PRPP and the counts obtained from breakdown products. Sherlock et al. used unlabeled PRPP and could not quantify the extent of degradation, likely resulting in some underestimation of PRPP’s ability to terminate transcription. The present data show that the affinity of the complex is at least of low micromolar affinity, placing it well within the range observed for complexes of PRPP with protein elements (Bera et al., 2003; Jørgensen et al., 2008).

Table 1. Dissociation constants for PRPP and ppGpp binding to the wild type and G96A T. mathranii aptamers with calculated fold specificity changes.

Dissociation constants for WT and G96A binding to PRPP and ppGpp
Construct Kd for PRPP Kd for ppGpp Fold specificity for PRPP over ppGpp Estimated magnitude of overall specificity switch
Wild type 2.0 ± 0.3 μM 91 ± 3 μM 46 ~40,000
G96A 1600 ± 200 μM 1.8 ± 0.1 μM ~0.001

In parallel with structural inquiries into the PRPP riboswitch, crystallization of native ppGpp aptamers was pursued. However, crystallization was unsuccessful with the subset of ppGpp aptamers tested. Considering the evident versatility of the ykkC motif and the overt similarity between the consensus sequences of ykkC RNA subtypes 2a and 2b, a specificity switch of the PRPP aptamer to a ppGpp aptamer was pursued via mutation as an alternative strategy.

Close examination of the consensus motifs of the PRPP and ppGpp riboswitch aptamers revealed that the ppGpp aptamer consensus sequence was almost entirely a subset of the PRPP aptamer consensus sequence, with the PRPP aptamer generally having more stringent requirements than the ppGpp aptamer. The most salient difference between the two consensus sequences is at position 96. In the PRPP aptamer, this position is >97% conserved as a guanosine, but this conservation is lost in the ppGpp aptamer. In the ppGpp aptamer, the lack of conservation in this region complicates the process of sequence alignment. However, it appears that this nucleotide is not always present and, when it is, it appears to be conserved as A, C or U, but not G (Sherlock et al., 2018a). The dramatic difference in conservation at this site suggested that it may be critical for differential recognition of PRPP and ppGpp.

We mutated position 96 in the T. mathranii PRPP aptamer from guanosine to adenosine, generating the G96A mutant. The wild-type aptamer shows low affinity for ppGpp (Kd = 91 ± 3 μM) and 46-fold greater affinity for PRPP (Kd = 2.0 ± 0.3 μM) (Table 1). Conversely, the G96A mutant binds ppGpp with an affinity equivalent to that of wild-type for PRPP (Kd = 1.8 ± 0.1 μM), but PRPP binding is abolished in the mutant up to 400 μM RNA (estimated Kd = 1600 ± 200 μM). The G96A mutant has approximately 900-fold higher affinity for ppGpp than PRPP. The G96A mutation thus strikingly resulted in approximately a 40,000-fold switch in ligand specificity from PRPP to ppGpp. The mutant’s affinity for ppGpp is well within the range of native aptamers tested (data not shown).

Co-crystal structure of the generated ppGpp aptamer and its ligand

Having shown that the G96A mutant is a ppGpp aptamer, we solved its crystal structure in the presence of ppGpp to 3.1 Å resolution. The crystallization conditions that reproducibly gave rise to co-crystals of the wild-type PRPP aptamer did not yield comparable results for co-crystals of the G96A mutant. However, the G96A mutant was found to crystallize in a separate condition that also produced crystals of the wild-type aptamer. The crystallization reagent used for G96A lacks barium, which was the most abundant divalent metal ion in the wild type crystallization condition. Potassium chloride, sodium chloride, and magnesium chloride were present in the crystallization drops. K+ and Mg2+ ions are observed in the mutant crystal structure. The best mutant crystal diffracted to a resolution of 3.1 Å and its structure was solved by molecular replacement using chain A of the PRPP riboswitch as an initial model. The asymmetric unit contained four aptamer molecules. Molecular replacement and refinement revealed robust density for the electron-dense pyrophosphate groups of ppGpp as well as its guanine base. In the initial solution and throughout refinement, the quality of the electron density was worse in chain D compared to chains A-C. The model of chain D is consistent with that of chains A-C, but is excluded from discussion in the text.

Overall, the architecture of the G96A mutant is very similar to that of the wild-type aptamer (Figure 1D). Notably, the 2FOFC map generated directly by molecular replacement showed no electron density in the former location of the ribose and phosphate of G96. Additional lack of electron density for the ribose of G95 and the phosphate of G97 immediately suggested that the G96A mutation caused major conformational rearrangement in this region.

The orientation of the ppGpp ligand was determined by examining an FOFC map where the input model lacked ppGpp. The positions of the 5′ and 3′ pyrophosphate groups of ppGpp are easily inferred from the available electron density data, which clearly show that the 5′ pyrophosphate occupies the former position of the pyrophosphate of PRPP. In this orientation, there is high electron density at the phosphates and lesser electron density at the 4′ and 5′ carbons, as expected (Figure 4A). This results in the ppGpp ribose having the opposite orientation of the PRPP ribose. The 5′ pyrophosphate is oriented toward P0 in the ppGpp structure, but the 5-phosphate is oriented away from P0 in the PRPP structure (Figure 1C,D, 2A and 4A). Several metal ions appear to associate with the pyrophosphate moieties. These were initially assigned as magnesium ions or water molecules, and subsequently assigned as more electron dense potassium ions due to implausibly low B factors after refinement. The positioning of these entities is highly variable among the molecules in the asymmetric unit, suggesting that they do not make essential contributions to ligand recognition, but may provide general charge stabilization.

Figure 4. The binding pocket of the G96A mutant in complex with ppGpp.

(A) Crystal structure of the ligand-binding site in chain A. ppGpp is depicted as sticks and colored by element with green carbons. Nucleotides are depicted as blue sticks. Metal ions are depicted as gray spheres. Individual nucleotides are labeled. An FO–FC map contoured at 3.0 σ is shown as a gray mesh. The map was calculated using an otherwise complete model lacking ppGpp and nearby metals. Relative to Figure 1, the structure is rotated 180° about the y axis. (B) Ligand interaction map. The map is colored essentially as in A. All RNA contacts to ppGpp are shown. Dashed black lines indicate hydrogen bonds. The grey bracket indicates base stacking. Black brackets indicate interactions shown in individual panels of Figure 5.

Figure 4.

Figure 4—figure supplement 1. A comparison of ppGpp modeled in the syn conformation and the anti conformation.

Figure 4—figure supplement 1.

Chain A is shown. ppGpp has green carbons and is colored by element. The Fo-Fc map was generated using an otherwise complete model lacking ppGpp and is shown contoured at 3.0 σ as a grey mesh.

The guanine base of ppGpp is modeled in the syn conformation (Figure 4—figure supplement 1). At 3.1 Å resolution, it is essential to inform this decision with the expected behavior of the chemical constituents in addition to the available electron density data. The shape of the electron density appears visibly more consistent with the syn conformation than the anti conformation. The chemical environment is also more plausible. In the syn conformation, the guanine base of the ligand forms three hydrogen bonds with C75 in a Watson-Crick base pair. In the anti conformation, the Hoogsteen face of the guanine base would form just one hydrogen bond with the Watson-Crick face of C75. Refinement of the ligand in the anti conformation created steric clashes or very short hydrogen bonds between the O6 of ppGpp and the N4 of C75, while simultaneously yielding unusually long hydrogen bonds (>3.5 Å) between the N7 of ppGpp and the N3 of C75. Modeling a Watson-Crick base pair (syn conformation) is consistent with a recent study showing that the equivalent of a C75U mutant in a native ppGpp riboswitch confers specificity to adenine-containing ligands over guanine-containing ligands (Sherlock et al., 2018a). The syn conformation of ppGpp was previously observed in a 2.0 Å X-ray crystal structure of an E. coli lysine decarboxylase, LcdI (Kanjee et al., 2011). Finally, a structural overlay of the wild-type and G96A structures at C75 shows that in the syn conformation, the base of ppGpp in the G96A structure occupies the same position as the base of G96 in the wild type structure.

The 3′ pyrophosphate of ppGpp consistently sits in a pocket lined with hydrogen bond donors (Figure 5A). The N4 of C77, the N1 and N2 of G48, and the 2′OH of A76 all make hydrogen bonds to the phosphate oxygens. A76 and G48 form a type I A-minor-like interaction in which the Watson-Crick edge of G48 interacts with the ligand, rather than being involved in a canonical base pair. While the position of the 5′-pyrophosphate of ppGpp is relatively invariable, the 3′-pyrophosphate occupies a slightly different position in each molecule of the asymmetric unit. Consistent with this model, the 3′ pyrophosphate atoms have slightly higher B factors than the rest of the ligand (~138 Å2 for the 3′ pyrophosphate compared to ~119 Å2 for the 5′ pyrophosphate). In chain A, the 3′-β-phosphate has one oxygen that accepts a hydrogen bond from the N1 of G48, a second oxygen that accepts a hydrogen bond from the N4 of C77, and a third, unrecognized oxygen. The recognition strategy is slightly different for chains B and C. While these observations may suggest genuine variation in recognition of the 3′ pyrophosphate, definitive interpretation is confounded by the comparatively lower resolution of this data set.

Figure 5. Notable contacts to the ppGpp ligand in chain A. ppGpp is depicted as sticks with green carbons and is colored by element.

Figure 5.

RNA is depicted as sticks with blue carbons and is colored by element. Dashed black lines indicate hydrogen bonds. (A) hydrogen bonds donated from amino groups in C77 and G48 to the 3′-β-phosphate of ppGpp, as well as the hydrogen bond network that constructs this part of the binding pocket. The 2′OH of A76 is close enough in chains B and C to form an additional hydrogen bond to the 3′-β-phosphate. (B) The Watson-Crick base pair between C75 in the RNA and the ppGpp ligand. (C) hydrogen bonds donated from amino groups in A5, G6, G104, and G105 to the 5′-β-phosphate of ppGpp.

The guanine base of ppGpp is buried in the RNA and is the focal point of ligand recognition. In the PRPP aptamer, the highly conserved C75 forms a Watson-Crick base pair with G96. The G96A mutant ppGpp aptamer recognizes its ligand through a similar Watson-Crick base pair between the G of ppGpp and C75 (Figure 5B). The guanine base of the ligand is also recognized via stacking with G6 and is 56% buried, compared to 38% of ppGpp overall. Such extensive recognition of ppGpp’s nucleobase suggests a likely mechanism for the mutant’s observed discrimination for ppGpp over PRPP. In the native PRPP aptamer, C75 is in the same location near the binding pocket, poised to form this interaction with ppGpp. However, the highly conserved G96 is also available to form this base pair and its spatial proximity to C75 raises its effective concentration, making it potentially able to outcompete ppGpp for this base pairing interaction. This model is consistent with the observation of low-affinity ppGpp binding (Kd = 91 ± 3 μM) in the wild type PRPP aptamer and explains why a single mutation at position 96 renders this aptamer capable of recognizing ppGpp with high affinity. The ribose is not recognized by the aptamer, leaving the guanine base and pyrophosphates as the major points of recognition.

Recognition of the 5′-pyrophosphate of ppGpp is extensive; its phosphate oxygens accept several hydrogen bonds from amino groups of conserved nucleobases (Figure 5C). The 5′-β-phosphate has three oxygen atoms that can accept hydrogen bonds from the aptamer. One of these oxygens accepts a hydrogen bond from the N6 group of A5. The second oxygen can accept hydrogen bonds from the N6 of A5 and N1 and N2 of G6, although it is not expected that these would all form simultaneously. The third oxygen can accept hydrogen bonds from the N1 and N2 of G105 and the N1 of G104. As with the previous oxygen, it is not expected that these would all form simultaneously. The 5′-α-phosphate appears to be unrecognized, consistent with its similar position to the poorly recognized α-phosphate of PRPP in the native structure.

Nucleotide A74 appears to play a conserved structural role in the PRPP and ppGpp aptamers. In all three ykkC subtypes it forms a noncanonical base pair with G6, which directly contacts PRPP and ppGpp, suggesting that it plays a role in positioning G6 (Figure 6—figure supplement 1). In the guanidine-I riboswitch, this nucleotide is not conserved. However, A6 in the guanidine-I crystal structure flips out to form the same non-canonical base pair with A68 (equivalent to A74) that is observed in the present study (Battaglia et al., 2017; Reiss et al., 2017). The lack of conservation at this position does not support a role in guanidine recognition, but this conserved interaction is observed in all three aptamers (Nelson et al., 2017).

The guanidine-I and PRPP ykkC aptamers each have an S-turn motif in the P3 helix. In the guanidine-I aptamer, the orientation of G88 is reversed relative to its stacking partners and G89 flips out of the helix. These are classic features of the S-turn. The guanidine-I riboswitch also possesses a cross-strand purine stack, a characteristic backbone kink on the opposite strand from the S-turn, and stabilizing hydrogen bonds, all of which were first observed in the S-turn of the conserved sarcin-ricin loop in the 23S rRNA (Correll et al., 1999). In the PRPP riboswitch, a similar S-turn motif exists at the equivalent position (Figure 6B). Equivalent to G89 in guanidine-I, G96 flips out and base pairs with C75 while also hydrogen bonding to PRPP. Notably, the cross-strand purine stack is absent in the PRPP riboswitch, but other S-turn characteristics are preserved. Conversely, the S-turn motif is abolished in the G96A mutant, and no contacts are observed between A96 and other nucleotides. Even more significantly, G95 does not possess the reverse ribose orientation that defines an S-turn. Rather, this region resembles a standard A-form helix with a single nucleotide bulge. The guanine of ppGpp replaces the flipped out guanosine of the former S-turn motif (G89/G96) (Figure 6), revealing that the S-turn is a key center of functional plasticity in the ykkC RNAs.

Figure 6. Comparison of the guanidine binding site in the guanidine aptamer, the M3 binding site in the PRPP aptamer, and the corresponding site in the G96A mutant.

(A) Watson-Crick base pairs with C75 in the wild-type and G96A aptamers. Wild-type and G96A aptamer structures are overlaid. Wild-type RNA is shown as gray sticks. G96A RNA is shown as blue sticks. The base and ribose of ppGpp are shown as green sticks. Hydrogen bonds are shown as dashed lines. Left: face-on view of the preserved base pair. Right: edge-on view of the same interaction. (B) The S-turn motif in the guanidine and PRPP aptamers, and the equivalent position in the ppGpp aptamer. The RNA is depicted as a blue cartoon. Guanidine is colored by element with white carbons. PRPP is colored by element with purple carbons. ppGpp is colored by element with green carbons. A red outline showcases the position of a conserved guanine base in all three RNA elements. Relative to Figure 1, the structure is rotated 180° about the y axis. (C) Nucleotides in the guanidine or M3 binding site, or the equivalent site in the ppGpp aptamer. The RNA is colored by element with blue carbons. Guanidine is colored by element with white carbons. Black dashed lines indicate hydrogen bonds. Solid black lines indicate coordination to a metal ion. Individual nucleotides, guanidine and M3 are labeled. Chain A of the PRPP and ppGpp aptamers is shown.

Figure 6.

Figure 6—figure supplement 1. Conserved interactions between P1 and P3.

Figure 6—figure supplement 1.

Nucleotides are labeled, depicted as sticks and colored by element with blue carbons. Dashed lines indicate hydrogen bonds. (A) Nucleotides A6 and A68 of the guanidine aptamer. (B) Nucleotides G6 and A74 of the PRPP aptamer. (C) Nucleotides G6 and A74 of the G96A mutant, a ppGpp aptamer. Chain A of the PRPP and ppGpp aptamers is shown.
Figure 6—figure supplement 2. Predicted model of switching in the tandem guanine-PRPP riboswitch from T. mathranii.

Figure 6—figure supplement 2.

The secondary structure of the RNA is represented as black lines. P0 nucleotides are colored dark red. Guanine aptamer nucleotides that may pair with P0 nucleotides are colored light red. P3 nucleotides are colored dark blue. Nucleotides in the terminator stem that may pair with P3 nucleotides are colored light blue. PRPP is represented as a blue ellipse, and guanine is represented as a red circle. The behavior of this IMPLY Boolean logic gate is shown in the center. (A) Predicted structure in the absence of PRPP and guanine. (B) Predicted structure in the presence of guanine. (C) Predicted structure in the presence of PRPP. (D) Predicted structure in the presence of PRPP and guanine. In this model, the presence of PRPP stabilizes P0 and destabilizes the guanine aptamer domain.
Figure 6—figure supplement 3. ppGpp purification and validation.

Figure 6—figure supplement 3.

(A) Anion-exchange chromatography of substrate and product standards. The ppGpp sample standard was purchased from TriLink BioTechnologies. (B) Anion-exchange chromatography of reactions with substrates GDP and ATP in the presence or absence of SAS1. To purify ppGpp for use in crystal trays, only fractions from the peak at ~16 column volumes were collected and pooled.

Discussion

Taken together, the present structural and biochemical data shed light on the evolvability of RNA as a whole and of the ykkC motif in particular. Just as residue C49 was previously used to distinguish guanidine aptamers from subtype 2 ykkC RNAs, here we show that G96 is the residue that differentiates PRPP and ppGpp aptamers. Clearly, the sequence space of the ykkC motif is rugged with potential functionality. The existence of ykkC RNAs with other gene contexts and unknown ligand specificity further reinforces the diversity of functions that this single RNA structural motif achieves with very small variations in consensus sequence (Nelson et al., 2017). Three-dimensional structural models of the wild type and G96A mutant aptamers reveal that the mechanism of specificity switching is recruitment of C75 as a primary effector of ligand recognition (Figure 6A). The presence or absence of the S-turn motif governs whether an RNA base or the ppGpp base can pair with C75, and therefore controls the specificity of the aptamer.

The wild-type aptamer featured in the current study binds PRPP at a location very near, but distinct from the binding pocket of the guanidine-I riboswitch. The P0 region, which is not present in the guanidine-I riboswitch, recognizes a portion of the larger ligand; metal ion M3 binds in the location where its parent motif binds guanidine (Figure 6C; see also Figure 3A). In the S-turn of the sarcin-ricin loop, the bulged G re-inserts into its helix to form a base triple. In an overlay of the S-turns of the sarcin-ricin loop, the guanidine-I riboswitch, and the PRPP riboswitch, the guanidino group of the bulged guanosine in the sarcin-ricin loop overlays almost exactly with the guanidinium cation, and both roughly overlay with metal M3 in the PRPP riboswitch. The common binding site of M3 in the PRPP riboswitch and guanidine in the guanidine riboswitch may be a case of molecular exaptation (the co-option of an existing feature for a new purpose). This is similar to a case documented in a ribozyme created by SELEX, suggesting that structured RNAs are functionally versatile and can readily adapt to new selection pressures (Lau et al., 2017). However, the evolutionary relationship of these two aptamers remains uncertain.

The present structural data shed additional light on the potential mechanism of switching in tandem guanine-PRPP aptamers (Sherlock et al., 2018b). The PRPP riboswitch (an ON switch), is often found immediately downstream of a guanine riboswitch (an OFF switch), in an IMPLY two-input logic gate (Figure 6—figure supplement 2). In these tandem systems, transcription proceeds in all cases except when guanine is present and PRPP is not. This suggests that PRPP binding disrupts formation of the guanine aptamer, allowing transcription to proceed when both ligands are present (Figure 6—figure supplement 2D). The T. mathranii PRPP aptamer studied in the present work is part of one of these tandem aptamer systems. Its predicted secondary structure shows that formation of the P0 stem of the PRPP aptamer and the P1 stem of the guanine aptamer are mutually exclusive. The present data reveal that the 5′ tail of the PRPP aptamer participates in P0 and plays a central role in PRPP recognition. In the proposed model, PRPP binding stabilizes P0 and disrupts the P1 helix of the guanine aptamer. The IMPLY character of this two-input gate may depend on the relative stabilities of the two helices, which in turn suggests that alternative logic gates could be constructed through mutation of P0 or P1. The ppGpp and T-box riboswitches are also often found in tandem. In contrast with the PRPP/guanine tandem system, the ppGpp and T-box riboswitches each maintain their own expression platform, suggesting that they fold independently. This is consistent with the AND behavior of this logic gate and the unimportance of the order of the two aptamers within the molecular circuit, but future studies in vivo are needed to confirm this.

The observed ability of the ykkC scaffold to reach new ligand specificities via mutation of a few key residues is reminiscent of other accounts of adaptability in both proteins and RNAs. In a clinically relevant contemporary example, β-lactamases evolve to expand their catalytic repertoire through mutations in a flexible loop. These mutations preserve the overall architecture of the protein while enabling it to metabolize new variations on a common antibiotic scaffold, contributing to the worldwide threat of antibiotic resistance (Banerjee et al., 1998; Hujer et al., 2001; Kurokawa et al., 2000; Wachino et al., 2004). The repurposing of protein scaffolds for the development of new catalysts has also been exploited in the design of novel enzymes including a Diels-Alderase (Siegel et al., 2010). In a related RNA example, the Tetrahymena ribozyme scaffold supports catalytic activities including self-cleavage, RNA polymerization, and peptide bond hydrolysis, though this is likely due to the placement of the substrates into physical proximity with each other (Kruger et al., 1982; Lau and Ferré-D’Amaré, 2016; Piccirilli et al., 1992; Zaug and Cech, 1986). Natural riboswitch aptamers subjected to directed evolution switch specificity, but maintain their overall fold (Porter et al., 2017). The existence of riboswitch variants that use the same scaffold but bind slightly different ligands, including the adenine/guanine and cyclic-di-GMP/cyclic-GMP-AMP riboswitch classes, has previously hinted at the adaptability of RNA elements (Kellenberger et al., 2015; Mandal et al., 2003; Mandal and Breaker, 2004; Ren et al., 2015; Serganov et al., 2004; Smith et al., 2009; Sudarsan et al., 2008). However, the present finding that a single conservative point mutation in the PRPP aptamer can dramatically alter both ligand specificity and tertiary structure reveals a striking example of RNA plasticity and speaks to the macromolecular evolvability of RNA.

A final key observation in this study is the direct visualization that an RNA element has evolved to specifically recognize PRPP. PRPP is a central metabolite, and likely has played that role since before the metabolic pathways of life’s last universal common ancestor (LUCA) were fully developed (Glansdorff et al., 2008). It is possible that PRPP was used for the synthesis of nucleotide precursors on the prebiotic Earth (Akouche et al., 2017). The finding that an extant RNA specifically recognizes PRPP lends credence to the hypothesis that RNA elements may have been capable of recognizing PRPP before the advent of coded protein synthesis.

Materials and methods

Key resources table.

Reagent type (species) or
resource
Designation Source or reference Identifiers
Chemical compound,
drug
ppGpp standard TriLink BioTechnologies TriLink Biotechnologies:
N-6001
Chemical compound,
drug
PRPP Millipore Sigma Millipore Sigma:P8296-
25MG
Commercial assay or
kit
Hampton Research
Natrix HT Screen
Hampton Research Hampton Research:HR2-
131
Commercial assay or
kit
Harvard Apparatus
cassettes
Harvard Apparatus Harvard Apparatus:742203
Peptide, recombinant
protein
Ribose phosphate
pyrophosphokinase
Abbexa Abbexa:abx072019
Sequence-based
reagent
T. mathranii genome NCBI NCBI:NC_014209.1
Software, algorithm CCP4 https://doi.org/10.1107/S0907444910045749 CCP4:7.0.042;
RRID:SCR_007255
Software, algorithm Coot https://doi.org/10.1107/S0907444904019158 Coot:0.8.6.1;
RRID:SCR_014222
Software, algorithm GraphPad GraphPad GraphPad:7.0a;
RRID:SCR_002798
Software, algorithm HKL2000 https://doi.org/10.1016/S0076-6879(97)76066-X HKL2000:v0.98.714;
RRID:SCR_015547
Software, algorithm Open Source PyMol SourceForge https://sourceforge.net/projects/pymol/ PyMol:v1.8.x;
RRID:SCR_000305

RNA transcription and purification

RNA was prepared essentially as in Reiss et al (Reiss et al., 2017). Plasmids containing ykkC PRPP riboswitch DNA from T. mathranii downstream of the T7 promoter were obtained from GeneArt at Thermo Fisher Scientific. The aptamer domain was extended at the 5′ end by one nucleotide to aid transcription by T7 polymerase (Salvail-Lacoste et al., 2013). Plasmid DNA was prepared using a QIAgen MaxiPrep kit and the accuracy of the sequence was verified using Sanger sequencing (Sanger et al., 1977). Template DNA for transcription was made using PCR with Phusion polymerase and primers 5′-TAATACGACTCACTATAGTGAAAGTGTACC-3′ and 5′-TACGAGTGAAACCTATCCTCCCG-3′. G96A transcription template was generated using the primers 5′-TAATACGACTCACTATAGTGAAAGTGTACC-3′ and 5′-TACGAGTGAAACCTATCCTCTCGGGCTTTTGTCC-3′. Template was purified using the Zymo Research DNA Clean and Concentrator 500 kit.

RNA was transcribed from 20 ng/μL PCR template using T7 polymerase in the presence of 80 mM HEPES-Na pH 7.5, 5 mM DTT, 1 mM spermidine, 0.12 mg/mL bovine serum albumin, 6 mM NTPs, 44 mM MgCl2, and 1 U/nL inorganic pyrophosphatase (Hartmann, 2009). Transcription reactions proceeded for approximately 4 hr at 37°C. Monomeric RNA was exchanged into gel filtration buffer (50 mM MES pH 6.2–6.3, 100 mM KCl, 10 mM MgCl2), filtered, and purified natively on a HiLoad 26/600 Superdex 75 pg gel filtration column in a cold room (6 ± 2°C). Monomers eluted at ca. 0.6 column volumes, and were pooled and concentrated to >100 μM.

Crystallization and structure determination of the wild-type and mutant aptamers

Crystals were grown using the microbatch-under-oil method with 2:1 paraffin:silicon oil. In all cases, crystals appeared within two days. Initial crystallization screening was performed using Hampton Research Natrix HT at 23 and 30°C. To produce the wild type crystals used for data collection, 2 μL of 150 μM RNA in 10 mM MgCl2, 10 mM KCl, 10 mM HEPES-KOH pH 7.5, and 10 mM PRPP (Millipore Sigma) was mixed with 1 μL of a solution of 80 mM sodium chloride, 20 mM barium chloride dihydrate, 40 mM sodium cacodylate trihydrate pH 5.6, 45% v/v (+/-)−2-methyl-2,4-pentanediol (MPD), and 12 mM spermine tetrahydrochloride and incubated at 30°C. To produce the G96A crystals, 150 μM RNA in 10 mM MgCl2, 10 mM KCl, 10 mM HEPES-KOH pH 7.5, and 1 mM ppGpp was mixed with a solution of 80 mM sodium chloride, 40 mM sodium cacodylate pH 7.0, 30% MPD, and 12 mM spermine (1 μL RNA solution plus 0.8 μL reagent) and incubated at 23°C.

Crystals were flash-frozen without further preparation. For the wild type aptamer, a solution was generated using molecular replacement with the ykkC guanidine riboswitch as an initial model (PDB ID: 5T83) (Reiss et al., 2017). For the G96A mutant, a solution was generated using molecular replacement with chain A of the PRPP riboswitch structure presented in this study as an initial model. Data were processed using HKL-2000 (Otwinowski and Minor, 1997). Model building was performed in Coot (Emsley and Cowtan, 2004).

The wild type aptamer crystallized in space group P21 with two molecules present in the asymmetric unit. Discussion is for the most part limited to chain A as there is better structural information for this entity than for chain B. The first component modeled was the RNA. Further unaccounted-for electron density was assigned to metal ions and water molecules. This process yielded a structure in which one significant area of electron density in each chain was unaccounted for. One molecule of PRPP and its two associated metal ions fit well in this area of density.

The G96A aptamer crystallized in space group P1 with four molecules in the asymmetric unit. Discussion in the manuscript is limited to chains A-C, due to chain D yielding generally poorer density. Overall, chain D is consistent with chains A-C, but more subject to error in individual atom positions. Regions disagreeing with the wild type (mainly in the S-turn) were deleted and re-modeled. Very large σ peaks in the difference Fourier map, corresponding to the very electron dense pyrophosphate moieties of ppGpp, were used to identify the ppGpp binding pocket.

Refinement of the two structures was performed with Refmac and Phenix (Adams et al., 2010; Winn et al., 2011). Refinement was concluded when no more entities could be modeled into the electron density and computational refinement ceased to produce improvements in Rwork and Rfree. Metal ions were identified by first modeling a magnesium ion and evaluating coordination geometry, B factors, and unaccounted-for density using difference Fourier methods, followed by reassignment where appropriate. The figures of the crystal structure were made in PyMOL (Schrödinger, n.d.). The ligand interaction map was made in ChemDraw.

Synthesis of (β-33P) PRPP and determination of the dissociation constant of the PRPP-aptamer complex

(β-33P) PRPP was synthesized using E. coli ribose-phosphate pyrophosphokinase (RPPK) obtained from Abbexa. 17.7 μg/mL RPPK was incubated at 37°C for two hours in the presence of 50 mM potassium phosphate dibasic pH 8, 10 mM ribose 5-phosphate, 5 mM MgCl2, and trace quantities of (γ-33P) ATP essentially as in Switzer and Gibson (Switzer and Gibson, 1978). PRPP and ATP were separated on a native 20% acrylamide gel at 4°C. PRPP was distinguished from the substrate by its faster rate of migration and eluted overnight in 400 μL dH2O at 4°C.

Purification of SAS1 for synthesis of ppGpp

SAS1 enzyme was expressed and purified based on the protocol in Steinchen et al. (Steinchen et al., 2015). Briefly, the SAS1 protein from B. subtilis was amplified by colony PCR, cloned into a pET-28aM vector, and transformed into E. coli BL21(DE3) cells. A 15 mL starter culture was used to inoculate 1.5 L Terrific Broth plus 50 μg/mL kanamycin and grown at 37°C. At OD600 ~0.8, expression was induced with 0.5 mM IPTG and the culture was shaken overnight at 18°C. Cells were then pelleted and lysed using a microfluidizer (lysis buffer: 50 mM Tris, pH 8.0, 300 mM NaCl, 20 mM imidazole, 20 mM MgCl2, 20 mM KCl) and the lysate was run on a nickel column. The protein was eluted from the column with 400 mM imidazole (elution buffer: 50 mM Tris, pH 8.0, 400 mM NaCl, 400 mM imidazole, 0.2 mM TCEP). A band running between 25 and 30 kDa was seen on an SDS-PAGE gel, indicating SAS1 was successfully eluted. The eluted protein was diluted in 50 mM Tris, pH 8.0 and run on a Q column (HiTrap Q column, 5 mL) to remove contaminants. Finally, the Q column fractions were pooled and run on a gel filtration column (Superdex 200, running buffer: 20 mM HEPES-Na, pH 7.5, 200 mM NaCl, 20 mM KCl, 20 mM MgCl2), and a peak eluted consistent with the relevant tetrameric assembly of the protein. The protein was concentrated and frozen at −80°C in aliquots for storage.

Synthesis and purification of ppGpp

The SAS1 protein accepts GDP (or GTP) and ATP as substrates and catalyzes the transfer of the β and γ phosphates from ATP onto the 3′ end of GDP or GTP to form ppGpp or pppGpp, respectively. To make unlabeled ppGpp for crystallography, a reaction setup based on the protocol of Steinchen et al (Steinchen et al., 2015) was used. Briefly, 5 mM GDP, 5 mM ATP, and 5 μM SAS1 were combined in reaction buffer (100 mM HEPES-Na, pH 7.5, 200 mM NaCl, 20 mM MgCl2, and 20 mM KCl) and incubated at 37°C for two hours. A chloroform extraction was performed to remove SAS1, followed by 10-fold dilution in ddH2O and purification by Q column (HiTrap Q HP, 5 mL column volume), where buffer A (10 mM HEPES-KOH, pH 7.5) was used to bind nucleotides to the column and a gradient of buffer B (2 M NaCl) was used to elute the nucleotides. Nucleotides eluted from the column such that the number of phosphates positively correlated with %B. ppGpp eluted last at ~15% buffer B (approximately 300 mM NaCl) (Figure 6—figure supplement 3). ppGpp was then precipitated by lithium chloride (LiCl) precipitation. Eluate from the Q column was brought to 1 M LiCl, 4 volumes of ethanol were added, and the tubes were frozen at −20°C before centrifuging at 6000 rpm in an Eppendorf F-45-18-11 fixed-angle centrifuge rotor at 4°C for 10 min to pellet the precipitate. The supernatant was discarded and the pellet was washed twice with cold (−20°C) ethanol, repeating the freezing and pelleting steps between each wash step. After pouring off the ethanol of the final wash, pellets were completely dried. A dry, white powder resulted. Concentration was calculated by measuring UV absorbance at 252 nm (ε252 = 13600 L mol−1 cm−1).

Synthesis and purification of (3′-β-32P)-ppGpp

A reaction mixture resembling that in the previous section was made, substituting 5 mM ATP for 150 μCi [γ-32P]-ATP (Perkin Elmer). (3′-β-32P)-ppGpp was purified using a 20% denaturing polyacrylamide gel to separate it from [γ-32P]-ATP. The band was soaked in 300 μL ddH2O overnight at 4°C. The gel slice was then filtered off and the solution containing (3′-β-32P)-ppGpp was frozen at −20°C for use in binding assays.

Determination of dissociation constants by equilibrium dialysis

The dissociation constants of the PRPP-RNA and ppGpp-RNA complexes were determined by equilibrium dialysis using cassettes with a 10 kDa cutoff obtained from Harvard Apparatus, essentially as in Reiss et al (Reiss et al., 2017). Trace quantities of radiolabeled ligand were dissolved in equilibrium dialysis buffer (50 mM HEPES-KOH, pH 7.5, 200 mM KCl, 20 mM MgCl2) and were added to one side of the cassette, while varying concentrations of RNA dissolved in the same buffer were added to the other side of the cassette. The cassettes were incubated at room temperature overnight with gentle shaking and recovered by centrifugation. For ppGpp, which experiences negligible amounts of degradation overnight, 20 μL of the recovered material was directly subjected to scintillation counting. For PRPP, 10 μL of the recovered material was subjected to scintillation counting, while another 10 μL was electrophoresed on a denaturing 20% acrylamide gel containing 7.5 M urea. The latter step allowed determination of the amount of PRPP remaining in each sample after overnight incubation at room temperature in the presence of magnesium. The fraction of ligand bound in each cassette was determined using the following equation:

F=(CPMRPR)(CPMLPL)CPMRPR

Where F is the fraction of PRPP bound. CPML and CPMR are the counts per minute measured via scintillation counting of the ligand and RNA sides of the cassette, respectively. PL and PR are the percentages of intact PRPP remaining as determined by gel electrophoresis for the ligand and RNA sides of the cassette, respectively. Fitting was performed in GraphPad Prism using the following equation:

F=Fmax[RNA]Kd+[RNA]

Where F is the fraction of PRPP bound, Fmax is the maximum fraction of PRPP bound, [RNA] is the concentration of RNA, and Kd is the dissociation constant.

All binding data consist of three technical replicates, of which the arithmetic mean and standard deviation are represented in Figure 1—figure supplement 2. All replicates were performed using a single stock of RNA from the same round of in vitro transcription and purification. Each data point in each replicate was collected using a different equilibrium dialysis cassette with independently diluted RNA solutions. Data were fit to a single-binding hyperbolic curve, with Bmax floating or constrained as follows. TmaWT binding to PRPP and TmaG96A binding to ppGpp fully reached saturation and Bmax was allowed to float. These Bmax values fit here should represent the fraction of radiolabeled ligand available for binding. TmaWT binding to ppGpp and TmaG96A binding to PRPP did not reach saturation, so the Bmax was constrained to equal the Bmax values for TmaG96A binding to ppGpp and TmaWT binding to PRPP, respectively. Values shown in Supplementary file 1 are the dissociation constant (Kd) from the hyperbolic fit plus or minus the standard error of the fit calculated by GraphPad Prism.

Secondary structure prediction

Secondary structure predictions were obtained from mFold using the default settings (Zuker, 2003). NCBI Reference Sequence: NC_014209.1, location 657606 to 657788 was used to predict the secondary structure of the aptamers in the presence of guanine and absence of PRPP. Location 657617 to 657800 was used to predict the secondary structures of the aptamers in the absence of guanine, in the presence of PRPP, and in the presence of both ligands. The secondary structure of the transcription terminator was predicted using location 657606 to 657841. The secondary structure deemed most likely by the program was used for interpretation. Bound guanine aptamer and bound PRPP aptamer secondary structure predictions are consistent with X-ray crystallography data.

Accession numbers

Coordinates have been deposited in the Protein Data Bank (PDB) with accession numbers 6CK5 for the wild-type PRPP aptamer and 6CK4 for the G96A ppGpp aptamer.

Acknowledgements

The authors thank the synchrotron beamline staff at the Northeastern Collaborative Access Team (NE-CAT) at the Advanced Photon Source (APS) for their assistance; Jimin Wang, who provided important help with structure determination, and Michael Strickler from the Yale Center for Structural Biology; Maddie Sherlock and Ron Breaker for providing data on the ykkC variant subtypes in advance of publication and helpful discussion; and David Hiller for comments and help with intellectual development of the manuscript. The authors acknowledge Brady Summers and Yong Xiong for assistance with purification of SAS1 protein. This work was funded by NIH grant GM022778 to SAS.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Scott A Strobel, Email: scott.strobel@yale.edu.

Timothy W Nilsen, Case Western Reserve University, United States.

Funding Information

This paper was supported by the following grant:

  • National Institutes of Health GM022778 to Scott A Strobel.

Additional information

Competing interests

No competing interests declared.

Author contributions

Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing, Determined the crystal structure of the wild-type aptamer and its affinity for PRPP.

Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing, Determined the crystal structure of the G96A mutant, its affinity for PRPP and ppGpp, and the affinity of the wild-type aptamer for ppGpp.

Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—review and editing.

Additional files

Supplementary file 1. X-ray crystallography statistics from data collection and refinement.
elife-36381-supp1.docx (114.9KB, docx)
DOI: 10.7554/eLife.36381.019
Transparent reporting form
DOI: 10.7554/eLife.36381.020
Reporting file 1
DOI: 10.7554/eLife.36381.021

Data availability

Diffraction data and coordinates have been deposited under the accession codes 6CK4 and 6CK5.

The following datasets were generated:

Knappenberger AJ, author; Reiss CW, author; Strobel SA, author. PRPP riboswitch from T. mathranii bound to PRPP. 2018 https://www.rcsb.org/structure/6CK5 Publicly available at the RCSB Protein Data Bank (accession no: 6CK5)

Reiss CW, author; Knappenberger AJ, author; Strobel SA, author. G96A mutant of the PRPP riboswitch from T. mathranii bound to ppGpp. 2018 https://www.rcsb.org/structure/6CK4 Publicly available at the RCSB Protein Data Bank (accession no: 6CK4)

The following previously published dataset was used:

Reiss CW, author; Xiong Y, author; Strobel SA, author. Structure of a guanidine-I riboswitch from S. acidophilus. 2018 https://www.rcsb.org/structure/5T83 Publicly available at the RCSB Protein Data Bank (accession no: 5T83)

References

  1. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallographica Section D Biological Crystallography. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akouche M, Jaber M, Maurel M-C, Lambert J-F, Georgelin T. Phosphoribosyl pyrophosphate: a molecular vestige of the origin of life on minerals. Angewandte Chemie. 2017;129:8028–8031. doi: 10.1002/ange.201702633. [DOI] [PubMed] [Google Scholar]
  3. Ancel LW, Fontana W. Plasticity, evolvability, and modularity in RNA. Journal of Experimental Zoology. 2000;288:242–283. doi: 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  4. Banerjee S, Pieper U, Kapadia G, Pannell LK, Herzberg O. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase. Biochemistry. 1998;37:3286–3296. doi: 10.1021/bi972127f. [DOI] [PubMed] [Google Scholar]
  5. Barrick JE, Corbino KA, Winkler WC, Nahvi A, Mandal M, Collins J, Lee M, Roth A, Sudarsan N, Jona I, Wickiser JK, Breaker RR. New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control. PNAS. 2004;101:6421–6426. doi: 10.1073/pnas.0308014101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Battaglia RA, Price IR, Ke A. Structural basis for guanidine sensing by the ykkC family of riboswitches. Rna. 2017;23:578–585. doi: 10.1261/rna.060186.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bera AK, Zhu J, Zalkin H, Smith JL. Functional dissection of the Bacillus subtilis pur operator site. Journal of Bacteriology. 2003;185:4099–4109. doi: 10.1128/JB.185.14.4099-4109.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Breaker RR. Riboswitches and the RNA world. Cold Spring Harbor Perspectives in Biology. 2012;4:a003566. doi: 10.1101/cshperspect.a003566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cashel M, Gallant J. Two compounds implicated in the function of the RC gene of Escherichia coli. Nature. 1969;221:838–841. doi: 10.1038/221838a0. [DOI] [PubMed] [Google Scholar]
  10. Cashel M, Kalbacher B. The control of ribonucleic acid synthesis in Escherichia coli V. Characterization of a nucleotide associated with the stringent response. The Journal of Biological Chemistry. 1970;245:2309–2318. [PubMed] [Google Scholar]
  11. Cashel M. Inhibition of RNA polymerase by ppGpp, a nucleotide accumulated during the stringent response to amino acid starvation in E. coli. Cold Spring Harbor Symposia on Quantitative Biology. 1970;35:407–413. doi: 10.1101/SQB.1970.035.01.052. [DOI] [Google Scholar]
  12. Chawla M, Chermak E, Zhang Q, Bujnicki JM, Oliva R, Cavallo L. Occurrence and stability of lone pair-π stacking interactions between ribose and nucleobases in functional RNAs. Nucleic Acids Research. 2017;45:11019–11032. doi: 10.1093/nar/gkx757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Correll CC, Wool IG, Munishkin A. The two faces of the Escherichia coli 23 S rRNA sarcin/ricin domain: the structure at 1.11 A resolution. Journal of Molecular Biology. 1999;292:275–287. doi: 10.1006/jmbi.1999.3072. [DOI] [PubMed] [Google Scholar]
  14. Crick FH. The origin of the genetic code. Journal of Molecular Biology. 1968;38:367–379. doi: 10.1016/0022-2836(68)90392-6. [DOI] [PubMed] [Google Scholar]
  15. Dalebroux ZD, Swanson MS. ppGpp: magic beyond RNA polymerase. Nature Reviews Microbiology. 2012;10:203–212. doi: 10.1038/nrmicro2720. [DOI] [PubMed] [Google Scholar]
  16. Dennis AL, Puskas M, Stasaitis S, Sandwick RK. The formation of a 1-5 phosphodiester linkage in the spontaneous breakdown of 5-phosphoribosyl-alpha-1-pyrophosphate. Journal of Inorganic Biochemistry. 2000;81:73–80. doi: 10.1016/S0162-0134(00)00117-3. [DOI] [PubMed] [Google Scholar]
  17. Draghi JA, Parsons TL, Wagner GP, Plotkin JB. Mutational robustness can facilitate adaptation. Nature. 2010;463:353–355. doi: 10.1038/nature08694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ebbole DJ, Zalkin H. Cloning and characterization of a 12-gene cluster from Bacillus subtilis encoding nine enzymes for de novo purine nucleotide synthesis. The Journal of Biological Chemistry. 1987;262:8274–8287. [PubMed] [Google Scholar]
  19. Ebbole DJ, Zalkin H. Bacillus subtilis pur operon expression and regulation. Journal of Bacteriology. 1989;171:2136–2141. doi: 10.1128/jb.171.4.2136-2141.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Egli M, Sarkhel S. Lone pair-aromatic interactions: to stabilize or not to stabilize. Accounts of Chemical Research. 2007;40:197–205. doi: 10.1021/ar068174u. [DOI] [PubMed] [Google Scholar]
  21. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallographica. Section D, Biological Crystallography. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  22. Evans GL, Gamage SA, Bulloch EM, Baker EN, Denny WA, Lott JS. Repurposing the chemical scaffold of the anti-arthritic drug lobenzarit to target tryptophan biosynthesis in Mycobacterium tuberculosis. ChemBioChem. 2014;15:852–864. doi: 10.1002/cbic.201300628. [DOI] [PubMed] [Google Scholar]
  23. Gaca AO, Colomer-Winter C, Lemos JA. Many means to a common end: the intricacies of (p)ppGpp metabolism and its control of bacterial homeostasis. Journal of Bacteriology. 2015;197:1146–1156. doi: 10.1128/JB.02577-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gilbert W. Origin of life: the RNA world. Nature. 1986;319:618. doi: 10.1038/319618a0. [DOI] [Google Scholar]
  25. Glansdorff N, Xu Y, Labedan B. The last universal common ancestor: emergence, constitution and genetic legacy of an elusive forerunner. Biology Direct. 2008;3:29. doi: 10.1186/1745-6150-3-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. González-Segura L, Witte JF, McClard RW, Hurley TD. Ternary complex formation and induced asymmetry in orotate phosphoribosyltransferase. Biochemistry. 2007;46:14075–14086. doi: 10.1021/bi701023z. [DOI] [PubMed] [Google Scholar]
  27. Hancock RD, Siddons CJ, Oscarson KA, Reibenspies JM. The structure of the 11-coordinate barium complex of the pendant-donor macrocycle 1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane: an analysis of the coordination numbers of barium(II) in its complexes. Inorganica Chimica Acta. 2004;357:723–727. doi: 10.1016/j.ica.2003.06.016. [DOI] [Google Scholar]
  28. Hartmann RK, editor. Handbook of RNA Biochemistry. 1st student ed. Weinheim: Wiley-VCH; 2009. [Google Scholar]
  29. Héroux A, White EL, Ross LJ, Kuzin AP, Borhani DW. Substrate deformation in a hypoxanthine-guanine phosphoribosyltransferase ternary complex. Structure. 2000;8:1309–1318. doi: 10.1016/S0969-2126(00)00546-3. [DOI] [PubMed] [Google Scholar]
  30. Hove-Jensen B, Andersen KR, Kilstrup M, Martinussen J, Switzer RL, Willemoës M. Phosphoribosyl diphosphate (PRPP): biosynthesis, enzymology, utilization, and metabolic significance. Microbiology and Molecular Biology Reviews. 2017;81:e00040-16. doi: 10.1128/MMBR.00040-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hove-Jensen B. Mutation in the phosphoribosylpyrophosphate synthetase gene (prs) that results in simultaneous requirements for purine and pyrimidine nucleosides, nicotinamide nucleotide, histidine, and tryptophan in Escherichia coli. Journal of Bacteriology. 1988;170:1148–1152. doi: 10.1128/jb.170.3.1148-1152.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hujer AM, Hujer KM, Bonomo RA. Mutagenesis of amino acid residues in the SHV-1 β-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance. Biochimica Et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 2001;1547:37–50. doi: 10.1016/S0167-4838(01)00164-9. [DOI] [PubMed] [Google Scholar]
  33. Jørgensen CM, Fields CJ, Chander P, Watt D, Burgner JW, Smith JL, Switzer RL. Pyr RNA binding to the Bacillus caldolyticus PyrR attenuation protein - characterization and regulation by uridine and guanosine nucleotides. FEBS Journal. 2008;275:655–670. doi: 10.1111/j.1742-4658.2007.06227.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Jendresen CB, Kilstrup M, Martinussen J. A simplified method for rapid quantification of intracellular nucleoside triphosphates by one-dimensional thin-layer chromatography. Analytical Biochemistry. 2011;409:249–259. doi: 10.1016/j.ab.2010.10.029. [DOI] [PubMed] [Google Scholar]
  35. Jensen KF, Houlberg U, Nygaard P. Thin-layer chromatographic methods to isolate 32P-labeled 5-phosphoribosyl-alpha-1-pyrophosphate (PRPP): determination of cellular PRPP pools and assay of PRPP synthetase activity. Analytical Biochemistry. 1979;98:254–263. doi: 10.1016/0003-2697(79)90138-6. [DOI] [PubMed] [Google Scholar]
  36. Jiménez A, Santos MA, Revuelta JL. Phosphoribosyl pyrophosphate synthetase activity affects growth and riboflavin production in Ashbya gossypii. BMC Biotechnology. 2008;8:67. doi: 10.1186/1472-6750-8-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kanjee U, Gutsche I, Alexopoulos E, Zhao B, El Bakkouri M, Thibault G, Liu K, Ramachandran S, Snider J, Pai EF, Houry WA. Linkage between the bacterial acid stress and stringent responses: the structure of the inducible lysine decarboxylase. The EMBO Journal. 2011;30:931–944. doi: 10.1038/emboj.2011.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kellenberger CA, Wilson SC, Hickey SF, Gonzalez TL, Su Y, Hallberg ZF, Brewer TF, Iavarone AT, Carlson HK, Hsieh YF, Hammond MC. GEMM-I riboswitches from Geobacter sense the bacterial second messenger cyclic AMP-GMP. PNAS. 2015;112:5383–5388. doi: 10.1073/pnas.1419328112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Khorana H, Fernandes J, Kornberg A. Pyrophosphorylation of ribose 5-phosphate in the enzymatic synthesis of 5-phosphorylribose 1-pyrophosphate. The Journal of Biological Chemistry. 1958;230:941–948. [PubMed] [Google Scholar]
  40. Kirschner M, Gerhart J. Evolvability. PNAS. 1998;95:8420–8427. doi: 10.1073/pnas.95.15.8420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kornberg A, Lieberman I, Simms ES. Enzymatic synthesis and properties of 5-phosphoribosylpyrophosphate. The Journal of Biological Chemistry. 1955;215:389–402. [PubMed] [Google Scholar]
  42. Kruger K, Grabowski PJ, Zaug AJ, Sands J, Gottschling DE, Cech TR. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena. Cell. 1982;31:147–157. doi: 10.1016/0092-8674(82)90414-7. [DOI] [PubMed] [Google Scholar]
  43. Kurokawa H, Yagi T, Shibata N, Shibayama K, Kamachi K, Arakawa Y. A new SHV-derived extended-spectrum beta -lactamase (SHV-24) That hydrolyzes ceftazidime through a Single-Amino-Acid substitution (D179G) in the omega -Loop. Antimicrobial Agents and Chemotherapy. 2000;44:1725–1727. doi: 10.1128/AAC.44.6.1725-1727.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Lau M, Ferré-D’Amaré A. Many activities, one structure: functional plasticity of ribozyme folds. Molecules. 2016;21:1570. doi: 10.3390/molecules21111570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lau MW, Trachman RJ, Ferré-D'Amaré AR. A divalent cation-dependent variant of the glmS ribozyme with stringent Ca2+ selectivity co-opts a preexisting nonspecific metal ion-binding site. RNA. 2017;23:355–364. doi: 10.1261/rna.059824.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Leontis NB, Westhof E. Geometric nomenclature and classification of RNA base pairs. RNA. 2001;7:499–512. doi: 10.1017/S1355838201002515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mandal M, Boese B, Barrick JE, Winkler WC, Breaker RR. Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other Bacteria. Cell. 2003;113:577–586. doi: 10.1016/S0092-8674(03)00391-X. [DOI] [PubMed] [Google Scholar]
  48. Mandal M, Breaker RR. Adenine riboswitches and gene activation by disruption of a transcription terminator. Nature Structural & Molecular Biology. 2004;11:29–35. doi: 10.1038/nsmb710. [DOI] [PubMed] [Google Scholar]
  49. Meola M, Yamen B, Weaver K, Sandwick RK. The catalytic effect of Mg2+ and imidazole on the decomposition of 5-phosphoribosyl-alpha-1-pyrophosphate in aqueous solution. Journal of Inorganic Biochemistry. 2003;93:235–242. doi: 10.1016/S0162-0134(02)00578-0. [DOI] [PubMed] [Google Scholar]
  50. Nelson JW, Atilho RM, Sherlock ME, Stockbridge RB, Breaker RR. Metabolism of free guanidine in Bacteria is regulated by a widespread riboswitch class. Molecular Cell. 2017;65:220–230. doi: 10.1016/j.molcel.2016.11.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Nygaard P, Smith JM. Evidence for a novel glycinamide ribonucleotide transformylase in Escherichia coli. Journal of Bacteriology. 1993;175:3591–3597. doi: 10.1128/jb.175.11.3591-3597.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. O'Farrell PH. The suppression of defective translation by ppGpp and its role in the stringent response. Cell. 1978;14:545–557. doi: 10.1016/0092-8674(78)90241-6. [DOI] [PubMed] [Google Scholar]
  53. Orgel LE. Evolution of the genetic apparatus. Journal of Molecular Biology. 1968;38:381–393. doi: 10.1016/0022-2836(68)90393-8. [DOI] [PubMed] [Google Scholar]
  54. Orgel LE. Prebiotic chemistry and the origin of the RNA world. Critical Reviews in Biochemistry and Molecular Biology. 2004;39:99–123. doi: 10.1080/10409230490460765. [DOI] [PubMed] [Google Scholar]
  55. Otwinowski Z, Minor W. [20] Processing of X-ray diffraction data collected in oscillation mode. Methods in Enzymology. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
  56. Paul BJ, Berkmen MB, Gourse RL. DksA potentiates direct activation of amino acid promoters by ppGpp. PNAS. 2005;102:7823–7828. doi: 10.1073/pnas.0501170102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Piccirilli JA, McConnell TS, Zaug AJ, Noller HF, Cech TR. Aminoacyl esterase activity of the Tetrahymena ribozyme. Science. 1992;256:1420–1424. doi: 10.1126/science.1604316. [DOI] [PubMed] [Google Scholar]
  58. Porter EB, Polaski JT, Morck MM, Batey RT. Recurrent RNA motifs as scaffolds for genetically encodable small-molecule biosensors. Nature Chemical Biology. 2017;13:295–301. doi: 10.1038/nchembio.2278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Potrykus K, Cashel M. (p)ppGpp: still magical? Annual Review of Microbiology. 2008;62:35–51. doi: 10.1146/annurev.micro.62.081307.162903. [DOI] [PubMed] [Google Scholar]
  60. Ran J, Hobza P. On the nature of bonding in lone pair···π-Electron complexes: ccsd(T)/Complete basis set limit calculations. Journal of Chemical Theory and Computation. 2009;5:1180–1185. doi: 10.1021/ct900036y. [DOI] [PubMed] [Google Scholar]
  61. Reiss CW, Xiong Y, Strobel SA. Structural basis for ligand binding to the Guanidine-I riboswitch. Structure. 2017;25:195–202. doi: 10.1016/j.str.2016.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Remy CN, Remy WT, Buchanan JM. Biosynthesis of the purines VIII. Enzymatic synthesis and utilization of α-5-phosphoribosylpyrophosphate. The Journal of Biological Chemistry. 1955;217:885–896. [PubMed] [Google Scholar]
  63. Ren A, Wang XC, Kellenberger CA, Rajashankar KR, Jones RA, Hammond MC, Patel DJ. Structural basis for molecular discrimination by a 3',3'-cGAMP sensing riboswitch. Cell Reports. 2015;11:1–12. doi: 10.1016/j.celrep.2015.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Ryals J, Little R, Bremer H. Control of rRNA and tRNA syntheses in Escherichia coli by Guanosine tetraphosphate. Journal of Bacteriology. 1982;151:1261–1268. doi: 10.1128/jb.151.3.1261-1268.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Salvail-Lacoste A, Di Tomasso G, Piette BL, Legault P. Affinity purification of T7 RNA transcripts with homogeneous ends using ARiBo and CRISPR tags. RNA. 2013;19:1003–1014. doi: 10.1261/rna.037432.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. PNAS. 1977;74:5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Sarkhel S, Desiraju GR. N—H…O, O—H…O, and C—H…O hydrogen bonds in protein-ligand complexes: Strong and weak interactions in molecular recognition. Proteins: Structure, Function, and Bioinformatics. 2003;54:247–259. doi: 10.1002/prot.10567. [DOI] [PubMed] [Google Scholar]
  68. Saxild HH, Nygaard P. Regulation of levels of purine biosynthetic enzymes in Bacillus subtilis: effects of changing purine nucleotide pools. Journal of General Microbiology. 1991;137:2387–2394. doi: 10.1099/00221287-137-10-2387. [DOI] [PubMed] [Google Scholar]
  69. Schindelin H, Zhang M, Bald R, Fürste JP, Erdmann VA, Heinemann U. Crystal structure of an RNA dodecamer containing the Escherichia coli Shine-Dalgarno sequence. Journal of Molecular Biology. 1995;249:595–603. doi: 10.1006/jmbi.1995.0321. [DOI] [PubMed] [Google Scholar]
  70. Schneider DA, Gourse RL. Relationship between growth rate and ATP concentration in Escherichia coli: a bioassay for available cellular ATP. The Journal of Biological Chemistry. 2004;279:8262–8268. doi: 10.1074/jbc.M311996200. [DOI] [PubMed] [Google Scholar]
  71. Schrödinger L. The PyMOL Molecular Graphics System. 1.82015
  72. Serganov A, Yuan YR, Pikovskaya O, Polonskaia A, Malinina L, Phan AT, Hobartner C, Micura R, Breaker RR, Patel DJ. Structural basis for discriminative regulation of gene expression by adenine- and guanine-sensing mRNAs. Chemistry & Biology. 2004;11:1729–1741. doi: 10.1016/j.chembiol.2004.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Sherlock ME, Sudarsan N, Breaker RR. Riboswitches for the alarmone ppGpp expand the collection of RNA-based signaling systems. PNAS. 2018a;115:6052–6057. doi: 10.1073/pnas.1720406115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Sherlock ME, Sudarsan N, Stav S, Breaker RR. Tandem riboswitches form a natural boolean logic gate to control purine metabolism in bacteria. eLife. 2018b;7:e33908. doi: 10.7554/eLife.33908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Siegel JB, Zanghellini A, Lovick HM, Kiss G, Lambert AR, St Clair JL, Gallaher JL, Hilvert D, Gelb MH, Stoddard BL, Houk KN, Michael FE, Baker D. Computational design of an enzyme catalyst for a stereoselective bimolecular diels-alder reaction. Science. 2010;329:309–313. doi: 10.1126/science.1190239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Singh SK, Das A. The n → π* interaction: a rapidly emerging non-covalent interaction. Physical Chemistry Chemical Physics. 2015;17:9596–9612. doi: 10.1039/C4CP05536E. [DOI] [PubMed] [Google Scholar]
  77. Smith KD, Lipchock SV, Ames TD, Wang J, Breaker RR, Strobel SA. Structural basis of ligand binding by a c-di-GMP riboswitch. Nature Structural & Molecular Biology. 2009;16:1218–1223. doi: 10.1038/nsmb.1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Steinchen W, Schuhmacher JS, Altegoer F, Fage CD, Srinivasan V, Linne U, Marahiel MA, Bange G. Catalytic mechanism and allosteric regulation of an oligomeric (p)ppGpp synthetase by an alarmone. PNAS. 2015;112:13348–13353. doi: 10.1073/pnas.1505271112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Strobel SA. Biological catalysis: repopulating the RNA world. Nature. 2001;411:1003–1006. doi: 10.1038/35082661. [DOI] [PubMed] [Google Scholar]
  80. Sudarsan N, Lee ER, Weinberg Z, Moy RH, Kim JN, Link KH, Breaker RR. Riboswitches in eubacteria sense the second messenger cyclic di-GMP. Science. 2008;321:411–413. doi: 10.1126/science.1159519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Switzer RL, Gibson KJ. Phosphoribosylpyrophosphate synthetase (ribose-5-phosphate pyrophosphokinase) from Salmonella typhimurium. Methods in Enzymology. 1978;51:3–11. doi: 10.1016/S0076-6879(78)51003-3. [DOI] [PubMed] [Google Scholar]
  82. Thompson RE, Li EL, Spivey HO, Chandler JP, Katz AJ, Appleman JR. Apparent stability constants of H+ and Mg2" complexes of 5-phosphoribosyl alpha-1-pyrophosphate. Bioinorganic Chemistry. 1978;9:35–45. doi: 10.1016/S0006-3061(00)82004-9. [DOI] [PubMed] [Google Scholar]
  83. van Ooyen AJ, Gruber M, Jorgensen P. The mechanism of action of ppGpp on rRNA synthesis in vitro. Cell. 1976;8:123–128. doi: 10.1016/0092-8674(76)90193-8. [DOI] [PubMed] [Google Scholar]
  84. Wachino J-i, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, Arakawa Y. Molecular characterization of a Cephamycin-Hydrolyzing and Inhibitor-Resistant class A -Lactamase, GES-4, possessing a single G170S substitution in the -Loop. Antimicrobial Agents and Chemotherapy. 2004;48:2905–2910. doi: 10.1128/AAC.48.8.2905-2910.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Wagner A. Robustness and evolvability: a paradox resolved. Proceedings of the Royal Society B: Biological Sciences. 2008;275:91–100. doi: 10.1098/rspb.2007.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Wagner GP, Altenberg L. Perspective: complex adaptations and the evolution of evolvability. Evolution. 1996;50:967–976. doi: 10.1111/j.1558-5646.1996.tb02339.x. [DOI] [PubMed] [Google Scholar]
  87. Weinberg Z, Nelson JW, Lünse CE, Sherlock ME, Breaker RR. Bioinformatic analysis of riboswitch structures uncovers variant classes with altered ligand specificity. PNAS. 2017;114:E2077–E2085. doi: 10.1073/pnas.1619581114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. White RH. Biosynthesis of methanopterin. Biochemistry. 1996;35:3447–3456. doi: 10.1021/bi952308m. [DOI] [PubMed] [Google Scholar]
  89. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS. Overview of the CCP4 suite and current developments. Acta Crystallographica. Section D, Biological Crystallography. 2011;67:235–242. doi: 10.1107/S0907444910045749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Woese CR, Dugre DH, Saxinger WC, Dugre SA. The molecular basis for the genetic code. PNAS. 1966;55:966–974. doi: 10.1073/pnas.55.4.966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Yaginuma H, Kawai S, Tabata KV, Tomiyama K, Kakizuka A, Komatsuzaki T, Noji H, Imamura H. Diversity in ATP concentrations in a single bacterial cell population revealed by quantitative single-cell imaging. Scientific Reports. 2015;4 doi: 10.1038/srep06522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Zaug AJ, Cech TR. The intervening sequence RNA of Tetrahymena is an enzyme. Science. 1986;231:470–475. doi: 10.1126/science.3941911. [DOI] [PubMed] [Google Scholar]
  93. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research. 2003;31:3406–3415. doi: 10.1093/nar/gkg595. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision letter

Editor: Timothy W Nilsen1

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article "Structures of two aptamers with differing ligand specificity reveal ruggedness in the functional landscape of RNA" for consideration by eLife. Your article has been reviewed by four peer reviewers, and the evaluation has been overseen by Timothy Nilsen as Reviewing Editor and James Manley as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The manuscript by Knappenberger et al. describes the exciting structure determination and analysis of the PRPP riboswitch aptamer domain, and a single nucleotide mutant that imparts effector specificity for ppGpp. This remarkable change in specificity is even more interesting because the wild-type aptamers are related closely to the recently described class of guanidium-I-sensing riboswitches derived from the ykkC superfamily.

The reviewers agreed that the work was important and in principle appropriate for eLife. However, each reviewer raised a number of potentially significant issues regarding the interpretation of the crystallographic data. These include the positioning of and stability of PRPP as well as the assignment of metal ion binding sites. Please address all of these concerns as thoroughly as possible. In this case any revised manuscript will require re-review by the same referees. Additionally we assume that the two Sherlock papers will be In Press if your revised manuscript is accepted.

Reviewer #1:

The manuscript by Knappenberger et al. describes the exciting structure determination and analysis of the PRPP riboswitch aptamer domain, and a single nucleotide mutant that imparts effector specificity for ppGpp. This remarkable change in specificity (reported by the authors as a~40,000-fold change) is even more interesting because the wild-type aptamers are related closely to the recently described class of guanidium-I-sensing riboswitches derived from the ykkC superfamily. Crystal structures reveal that the PRPP sensor and mutant bind their ligands in a four-helix junction that utilizes a novel P0 helix – not found in the guanidium-I riboswitch – to impart new ligand binding properties. The added P0 structural element has implications for the gene regulatory mechanisms of tandem guanine-PRPP riboswitch sensors that work synergistically to compose a dual input "imply" gate that shares an expression platform. Details of ligand binding are described including the association of metal ions. An interesting aspect of sensing is the existence of an S-turn motif that is integral to guanidinium or PRPP sensing. However, extrusion of a key S-turn guanine obstructs the base in ppGpp from binding. The latter block necessitates an S-turn conformational adjustment caused by a single G96A point mutant that imparts ppGpp effector recognition over PRPP.

Overall, the work is very interesting and should be of broad interest to the journal audience. However, there are some technical details regarding the assignment of the ions and orientation of the PPRP effector that should be addressed to provide greater confidence in the crystallographic model. Another point of concern is citing unpublished or "in press" work, which may not agree with the journal policy.

1) Introduction, second paragraph and throughout the manuscript, the authors make reference to Sherlock et al. in press as two separate manuscripts. Please provide the "Sherlock et al. in press" manuscripts with more complete information (i.e., all authors, title, journal). Since there are two manuscripts, they need to be distinguished as 2018a or 2018b, or by the appropriate journal style.

2) Introduction, fourth and fifth paragraphs, and elsewhere. The authors refer to "Sherlock et al., unpublished." This may not conform the journal guidelines for citations. The reviewer objects to citing unpublished work because it is not a rigorous source of information that is transparent for the journal readership.

3) Supplementary file 1. The reviewer has a number of suggestions to improve the table.

First, the unit cell cannot be known to an accuracy of 1/1000th Å based on the mode of data collection. HKL2000 will report the errors and these could be indicated or the cell should be reported to 1/10th of an Ångstrom. The same is true of the angles.

Second, the reviewer recommends using Rp.i.m. instead of Rmerge. The former accounts for redundancy in the data collection and should replace the latter (see Karplus and Diedrichs (Curr Opin Struct Biol 34, 60) and Weiss (J. Appl. Cryst. 34, 130-135). This metric is also provided by HKL2000.

4) Figure 2. The mode of metal ion coordination is unclear based on the drawing. To clarify the scheme, please provide the name of the nucleotide atom in panel B that forms an interaction with PRPP. The underlying reason for this request is that the ligand could be modeled in a different manner in the electron density.

5) One aspect of the presentation that could be improved is to provide greater evidence for the orientation of modeled PRPP. Rotation of PRPP by 180° about the y-axis would place the pyrophosphate into M2. The reviewer noted this possibility prior to reading the 180° rotation of ppGpp in the ensuing section. In this respect, more should be done to explore this possibility as a supplemental figure. For example, compare the SA omit electron density for both orientations (or use averaged kicked maps or composite omit rebuild maps, which are likely the best – but slowest to run; use 2Fo-Fc coefficients). How do the Rfree values compare for each orientation? How do the real space correlation coefficients compare?

6) It is unclear what metal ions are present in sites M1, M2 and M3. These are stated to be consistent with Ba2+ (subsection “The structure of the wild-type PRPP aptamer and a single point mutant ppGpp aptamer”, seventh paragraph) but actual distance information and geometry should be provided. Why? It seems unusual that Ba2+ would bind in place of Mg2+ since the latter has significantly shorter coordination distances and distinct octahedral geometry. Mg2+ is the expected intracellular ion of course. Anomalous scattering from Ba2+ might help to more definitively model the ions, which is still difficult to define at this resolution. In these respects, the coordination distances between the ions and the ligands should be mentioned. (the aforementioned paragraph notes the coordination of M2 is consistent within inner sphere coordination. Please be more specific). What are the B-factors of the Ba2+ ions? If they are modeled as Mg2+, are they unreasonably low? If another contour level is add to the maps, is the s-to-n consistent with Ba2+ (e.g., 10 σ or greater peaks).

7) The observation of Ba2+ in the complex with PRPP suggests that the ion should be sufficient for binding in equilibrium dialysis experiments. The experimental methods describe the use of Mg2+ (subsection “Determination of dissociation constants by equilibrium dialysis”, first paragraph) Was Ba2+ tried? If Ba2+ showed binding, this could be a stronger case for the observation of the assignment of Ba2+ in the electron density maps. The reviewer realizes that these are not easy experiments, so analysis with Ba2+ may not be feasible. Why not use isothermal titration calorimetry?

Reviewer #2:

The study by Knappenberger et al. characterizes the structure of a subtype of the guanidine-I riboswitch that binds the nucleotide precursor PRPP. The study goes even further to describe the structure of a point mutant that switches specificity to the bacterial alarmone ppGpp. By detailing how small nucleotide changes can alter the specificity of riboswitch variants, the authors show how structured RNAs can readily evolve new functions. The descriptions of ligand recognition by each riboswitch is very thoroughly and the structure guided rationalization of altered ligand specificity between guanidine-I, PRPP, and ppGpp riboswitches is strong. Overall, the study is significant for describing ligand recognition by two newly characterized riboswitches and for looking at the evolution of riboswitch variants through a structural lens. The study should be of interest to the broad readership of the journal. I do have a few concerns:

1) The I/sigmaI values reported for each structure are on the low side (1.27 for PRPP and 0.67 for ppGpp) and the difference between Rfree and Rwork for each structure is on the high side. Perhaps the structures have been refined to an artificially high resolution. Furthermore, both structures appear to be missing portions of the chain.

2) The authors should cite the paper by Battaglia et al. describing the structure of guanidine-I.

Reviewer #3:

This paper describes the structural elucidation of the PRPP riboswitch aptamer (ykkC 2b subtype) and a synthetic ppGpp riboswitch aptamer made by a G96A point mutation of the prior aptamer, as representative of the ykkC 2a subtype. This research group previously had solved the structure of the ykkC 1 subtype (guanidine-I), and there are two main points of interest for this current work: (1) comparison of these two new structures to the guanidine-I structure provides detailed insight into how a riboswitch scaffold can dramatically switch ligand specificity, from a positively charged ion to highly negatively charged compounds; (2) comparison between the two new structures demonstrates how a point mutation leads to full switch in ligand specificity, as both WT and G96A riboswitches are ~50-900 fold selective against the non-cognate ligand. Together these points highlight the functional plasticity of RNA; other examples have been shown before, but none with as dramatic a change in the ligand structure. The authors also state that the PRPP riboswitch provides evidence for the RNA world theory.

Overall, the work is very solid – the structures are to 2.5 and 3.1 Å resolution, so the authors are careful to point out what they cannot conclude due to limitations of resolution, and to present other support for choices made regarding modeled ligand conformations. Each structure presented unique challenges that had to be overcome: PRPP is a highly unstable ligand, whereas the native ppGpp aptamers did not crystallize and led to use of the G96A mutant. There is a strong reliance on unpublished data from Sherlock et al., so these two manuscripts are linked – this reviewer feels that this paper relies on the other to provide more biological context. However, there is definitely insight gained from these structures: specifically, the way that the guanosine base in ppGpp replaces G96 in the PRPP structure is satisfying to see; and surprisingly, how the ligand orientation is completely flipped.

1) Compound identity for synthesized PRPP and ppGpp. This is not a chemistry journal, but how did authors validate compound identity? Because "riboswitch binds synthesized compound, therefore compound identity is X" would be circular reasoning. Is the resolution high enough to serve as validation of ligand identity? Also was wondering if resolution was high enough to show that ligands were not hydrolyzed in the structure, e.g. GMP+PPi instead of GTP is common.

2) – "A common ancestral RNA likely diverged to recognize guanidine, PRPP, and ppGpp in spite of the chemical and structural diversity among these ligands" This line is too speculative. What evidence do you have that one became three, vs. first was guanidine, then branched to two new, or vice versa?

3) Figure 1—figure supplement 1 – "PRPP" control sample, how was this sample treated? It is unclear if it was treated under same reaction conditions, although text suggests PRPP would be totally degraded under those conditions (but not shown?)

4) Figure 2 – Results text state that M3 "forms a water-mediated coordination to the 5-phosphate" but this is not shown in B?

5) Figure 6C – does resolution allow for assignment that there is no ion or water bound in the guanidine/metal pocket shown?

6) Discussion: It should be made clear that this study does not demonstrate that the G96A mutation is sufficient to alter gene regulation in vivo, although the aptamer selectivity is altered. See Mandal and Breaker 2004 for precedence. Along these lines, what is the range of% identity for natural PRPP and ppGPP riboswitches? This would be helpful to know.

eLife. 2018 Jun 7;7:e36381. doi: 10.7554/eLife.36381.030

Author response


Reviewer #1:

[…] Overall, the work is very interesting and should be of broad interest to the journal audience. However, there are some technical details regarding the assignment of the ions and orientation of the PPRP effector that should be addressed to provide greater confidence in the crystallographic model. Another point of concern is citing unpublished or "in press" work, which may not agree with the journal policy.

1) Introduction, second paragraph and throughout the manuscript, the authors make reference to Sherlock et al. in press as two separate manuscripts. Please provide the "Sherlock et al. in press" manuscripts with more complete information (i.e., all authors, title, journal). Since there are two manuscripts, they need to be distinguished as 2018a or 2018b, or by the appropriate journal style.

2) Introduction, fourth and fifth paragraphs, and elsewhere. The authors refer to "Sherlock et al., unpublished." This may not conform the journal guidelines for citations. The reviewer objects to citing unpublished work because it is not a rigorous source of information that is transparent for the journal readership.

One significant issue raised by the reviewers and the editors was the status of the work cited from the Breaker lab. We are happy to report that the two Sherlock et al. papers referenced in our work have been accepted by eLife and PNAS. This enables us to properly cite their work in this revised manuscript. Sherlock, Sudarsan, and Breaker 2018 is not yet available online as of our re-submission, but it is expected to appear in the very near future.

3) Supplementary file 1. The reviewer has a number of suggestions to improve the table.

First, the unit cell cannot be known to an accuracy of 1/1000th Å based on the mode of data collection. HKL2000 will report the errors and these could be indicated or the cell should be reported to 1/10th of an Ångstrom. The same is true of the angles.

Corrected.

Second, the reviewer recommends using Rp.i.m. instead of Rmerge. The former accounts for redundancy in the data collection and should replace the latter (see Karplus and Diedrichs (Curr Opin Struct Biol 34, 60) and Weiss (J. Appl. Cryst. 34, 130-135). This metric is also provided by HKL2000.

Rp.i.m. is now included in Supplementary file 1 in addition to Rmerge.

4) Figure 2. The mode of metal ion coordination is unclear based on the drawing. To clarify the scheme, please provide the name of the nucleotide atom in panel B that forms an interaction with PRPP. The underlying reason for this request is that the ligand could be modeled in a different manner in the electron density.

New supplemental figure (Figure 1—figure supplement 2) shows coordination distances to the three metals and the text now describes the ambiguities inherent in metal assignment at this resolution.

5) One aspect of the presentation that could be improved is to provide greater evidence for the orientation of modeled PRPP. Rotation of PRPP by 180° about the y-axis would place the pyrophosphate into M2. The reviewer noted this possibility prior to reading the 180° rotation of ppGpp in the ensuing section. In this respect, more should be done to explore this possibility as a supplemental figure. For example, compare the SA omit electron density for both orientations (or use averaged kicked maps or composite omit rebuild maps, which are likely the best – but slowest to run; use 2Fo-Fc coefficients). How do the Rfree values compare for each orientation? How do the real space correlation coefficients compare?

We modeled PRPP in the alternative orientation suggested by the reviewer. In this orientation, the Rfree rises from 0.2523 to 0.2537. It results in a short (2 Å) hydrogen bond between PRPP and the N1 atom of G6, and forces two non-bridging oxygens in the pyrophosphate into implausibly close proximity (1.8 Å) with one another. All indications are that this is not the correct orientation of the molecule within the RNA.

6) It is unclear what metal ions are present in sites M1, M2 and M3. These are stated to be consistent with Ba2+ (subsection “The structure of the wild-type PRPP aptamer and a single point mutant ppGpp aptamer”, seventh paragraph) but actual distance information and geometry should be provided. Why? It seems unusual that Ba2+ would bind in place of Mg2+ since the latter has significantly shorter coordination distances and distinct octahedral geometry. Mg2+ is the expected intracellular ion of course. Anomalous scattering from Ba2+ might help to more definitively model the ions, which is still difficult to define at this resolution. In these respects, the coordination distances between the ions and the ligands should be mentioned. (the aforementioned paragraph notes the coordination of M2 is consistent within inner sphere coordination. Please be more specific). What are the B-factors of the Ba2+ ions? If they are modeled as Mg2+, are they unreasonably low? If another contour level is add to the maps, is the s-to-n consistent with Ba2+ (e.g., 10 σ or greater peaks).

7) The observation of Ba2+ in the complex with PRPP suggests that the ion should be sufficient for binding in equilibrium dialysis experiments. The experimental methods describe the use of Mg2+ (subsection “Determination of dissociation constants by equilibrium dialysis”, first paragraph) Was Ba2+ tried? If Ba2+ showed binding, this could be a stronger case for the observation of the assignment of Ba2+ in the electron density maps. The reviewer realizes that these are not easy experiments, so analysis with Ba2+ may not be feasible. Why not use isothermal titration calorimetry?

We thank the reviewer for raising this important point. We have carefully reviewed the metal assignments for M1, M2, and M3 within the PRPP structure. Because there is a mixture of divalent metals in the crystal condition (both Mg2+ and Ba2+ are present), partial occupancy is a potential complicating factor. Both Mg2+ and Ba2+ support PRPP binding and do so at similar affinities (see above). The data support the assignment of M1 and M3 as having significant occupancy by Ba2+. Assignment of M1 or M3 as magnesium result in very large positive peaks occur in the Fo-Fc map. Upon closer inspection, there is reasonable case to be made for assigning M2 as Mg2+. Although coordination distances (~2.8 Å to 3.0 Å) are longer than expected for Mg2+, the B factor (64 Å2) and difference map are reasonable. All three sites are likely to be partially occupied by both Mg2+ and Ba2+ which complicates the assignments. A sentence to this effect has been added to the text.

Reviewer #2:

[…] 1) The I/sigmaI values reported for each structure are on the low side (1.27 for PRPP and 0.67 for ppGpp) and the difference between Rfree and Rwork for each structure is on the high side. Perhaps the structures have been refined to an artificially high resolution.

We used a combination of the CC1/2 and the point at which the slope of the Wilson plot approaches zero to assign cutoff points. We used the widely accepted CC1/2 value of 0.15 to cut the data.

Furthermore, both structures appear to be missing portions of the chain.

These nucleotides are disordered in the structure so we did not model them.

2) The authors should cite the paper by Battaglia et al. describing the structure of guanidine-I.

We particularly thank the reviewers for catching this omission. The citation has been added.

Reviewer #3:

[…] 1) Compound identity for synthesized PRPP and ppGpp. This is not a chemistry journal, but how did authors validate compound identity? Because "riboswitch binds synthesized compound, therefore compound identity is X" would be circular reasoning. Is the resolution high enough to serve as validation of ligand identity? Also was wondering if resolution was high enough to show that ligands were not hydrolyzed in the structure, e.g. GMP+PPi instead of GTP is common.

PRPP was purchased from Σ Aldrich and validated by the company. ppGpp was made using previously established methods and verified by comparison of anion-exchange retention time with a ppGpp standard (purchased from TriLink BioTechnologies). A supplemental figure has been added to show this validation (Figure 6—figure supplement 3).

2) "A common ancestral RNA likely diverged to recognize guanidine, PRPP, and ppGpp in spite of the chemical and structural diversity among these ligands" This line is too speculative. What evidence do you have that one became three, vs. first was guanidine, then branched to two new, or vice versa?

We did not intend to suggest an order of divergence between these RNA classes. The text has been revised to clarify this point.

3) Figure 1—figure supplement 1 – "PRPP" control sample, how was this sample treated? It is unclear if it was treated under same reaction conditions, although text suggests PRPP would be totally degraded under those conditions (but not shown?)

Explanatory text has been added to the legend of Figure 1—figure supplement 1.

4) Figure 2 – Results text state that M3 "forms a water-mediated coordination to the 5-phosphate" but this is not shown in B?

Added.

5) Figure 6C – does resolution allow for assignment that there is no ion or water bound in the guanidine/metal pocket shown?

We do see ions and water molecules in this area, but they are too distant to be true coordination or hydrogen bonding contacts. Positioning of these species varies among chains in the asymmetric unit.

6) Discussion: It should be made clear that this study does not demonstrate that the G96A mutation is sufficient to alter gene regulation in vivo, although the aptamer selectivity is altered. See Mandal and Breaker 2004 for precedence. Along these lines, what is the range of% identity for natural PRPP and ppGPP riboswitches? This would be helpful to know.

Done.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Figure 1—source data 1. Summary of fitted binding data without Bmax constraints.
    DOI: 10.7554/eLife.36381.006
    Figure 1—source data 2. Raw binding data.
    DOI: 10.7554/eLife.36381.007
    Supplementary file 1. X-ray crystallography statistics from data collection and refinement.
    elife-36381-supp1.docx (114.9KB, docx)
    DOI: 10.7554/eLife.36381.019
    Transparent reporting form
    DOI: 10.7554/eLife.36381.020
    Reporting file 1
    DOI: 10.7554/eLife.36381.021

    Data Availability Statement

    Diffraction data and coordinates have been deposited under the accession codes 6CK4 and 6CK5.

    The following datasets were generated:

    Knappenberger AJ, author; Reiss CW, author; Strobel SA, author. PRPP riboswitch from T. mathranii bound to PRPP. 2018 https://www.rcsb.org/structure/6CK5 Publicly available at the RCSB Protein Data Bank (accession no: 6CK5)

    Reiss CW, author; Knappenberger AJ, author; Strobel SA, author. G96A mutant of the PRPP riboswitch from T. mathranii bound to ppGpp. 2018 https://www.rcsb.org/structure/6CK4 Publicly available at the RCSB Protein Data Bank (accession no: 6CK4)

    The following previously published dataset was used:

    Reiss CW, author; Xiong Y, author; Strobel SA, author. Structure of a guanidine-I riboswitch from S. acidophilus. 2018 https://www.rcsb.org/structure/5T83 Publicly available at the RCSB Protein Data Bank (accession no: 5T83)


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES